WO2014187744A1 - Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen („on-demand") kontrazeption - Google Patents
Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen („on-demand") kontrazeption Download PDFInfo
- Publication number
- WO2014187744A1 WO2014187744A1 PCT/EP2014/060103 EP2014060103W WO2014187744A1 WO 2014187744 A1 WO2014187744 A1 WO 2014187744A1 EP 2014060103 W EP2014060103 W EP 2014060103W WO 2014187744 A1 WO2014187744 A1 WO 2014187744A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methyl
- carboxamide
- piperidin
- indazole
- methoxyethyl
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 66
- 101001117519 Homo sapiens Prostaglandin E2 receptor EP2 subtype Proteins 0.000 claims abstract description 81
- 101000836978 Homo sapiens Sperm-associated antigen 11B Proteins 0.000 claims abstract description 74
- 229940124638 COX inhibitor Drugs 0.000 claims abstract description 64
- 229940044551 receptor antagonist Drugs 0.000 claims abstract description 64
- 239000002464 receptor antagonist Substances 0.000 claims abstract description 64
- 238000000034 method Methods 0.000 claims abstract description 59
- 230000001568 sexual effect Effects 0.000 claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 102100028654 Sperm-associated antigen 11B Human genes 0.000 claims abstract 7
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims description 165
- -1 4'-fluorobiphenyl-4-yl Chemical group 0.000 claims description 148
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 127
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 124
- 125000004567 azetidin-3-yl group Chemical group N1CC(C1)* 0.000 claims description 54
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 50
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 37
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims description 34
- 239000000126 substance Substances 0.000 claims description 33
- 230000035558 fertility Effects 0.000 claims description 31
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 27
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 claims description 22
- 239000002253 acid Substances 0.000 claims description 22
- 229960001929 meloxicam Drugs 0.000 claims description 22
- 229960002702 piroxicam Drugs 0.000 claims description 20
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 claims description 20
- 229960000905 indomethacin Drugs 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 15
- 239000003814 drug Substances 0.000 claims description 14
- YNXBXETVFQQCFR-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 YNXBXETVFQQCFR-UHFFFAOYSA-N 0.000 claims description 14
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 claims description 12
- 229960001259 diclofenac Drugs 0.000 claims description 12
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims description 12
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 claims description 11
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims description 9
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims description 9
- 229960001680 ibuprofen Drugs 0.000 claims description 9
- 229960002009 naproxen Drugs 0.000 claims description 9
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims description 9
- 229960000965 nimesulide Drugs 0.000 claims description 9
- HYWYRSMBCFDLJT-UHFFFAOYSA-N nimesulide Chemical compound CS(=O)(=O)NC1=CC=C([N+]([O-])=O)C=C1OC1=CC=CC=C1 HYWYRSMBCFDLJT-UHFFFAOYSA-N 0.000 claims description 9
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 9
- 229920000858 Cyclodextrin Polymers 0.000 claims description 8
- 239000004237 Ponceau 6R Substances 0.000 claims description 8
- 229960000590 celecoxib Drugs 0.000 claims description 8
- TZRHLKRLEZJVIJ-UHFFFAOYSA-N parecoxib Chemical compound C1=CC(S(=O)(=O)NC(=O)CC)=CC=C1C1=C(C)ON=C1C1=CC=CC=C1 TZRHLKRLEZJVIJ-UHFFFAOYSA-N 0.000 claims description 8
- 235000019238 ponceau 6R Nutrition 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 229960000371 rofecoxib Drugs 0.000 claims description 7
- HEEKRIQAHZLSAV-UHFFFAOYSA-N 1h-indazole-5-carboxamide Chemical compound NC(=O)C1=CC=C2NN=CC2=C1 HEEKRIQAHZLSAV-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 229960004945 etoricoxib Drugs 0.000 claims description 6
- MNJVRJDLRVPLFE-UHFFFAOYSA-N etoricoxib Chemical compound C1=NC(C)=CC=C1C1=NC=C(Cl)C=C1C1=CC=C(S(C)(=O)=O)C=C1 MNJVRJDLRVPLFE-UHFFFAOYSA-N 0.000 claims description 6
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims description 6
- 229960000991 ketoprofen Drugs 0.000 claims description 6
- 229960004662 parecoxib Drugs 0.000 claims description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 6
- LZNWYQJJBLGYLT-UHFFFAOYSA-N tenoxicam Chemical compound OC=1C=2SC=CC=2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 LZNWYQJJBLGYLT-UHFFFAOYSA-N 0.000 claims description 6
- 229960002871 tenoxicam Drugs 0.000 claims description 6
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 claims description 6
- 229960002004 valdecoxib Drugs 0.000 claims description 6
- PKFOPFNPUINPGP-UHFFFAOYSA-N 2-[[1-(2-fluoro-4-methylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C)C=C1F PKFOPFNPUINPGP-UHFFFAOYSA-N 0.000 claims description 5
- VHCYFVZPUIFDNS-UHFFFAOYSA-N 2-[[1-(2-fluoro-4-propan-2-yloxybenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC(C)C)C=C1F VHCYFVZPUIFDNS-UHFFFAOYSA-N 0.000 claims description 5
- MQUMREJWSAISBI-UHFFFAOYSA-N 2-[[1-(4-bromo-3-methylbenzoyl)piperidin-4-yl]methyl]-N-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Br)c(C)c3)cc2c1C MQUMREJWSAISBI-UHFFFAOYSA-N 0.000 claims description 5
- RJJSKKUCLQTRSG-UHFFFAOYSA-N 2-[[1-(4-chloro-2-fluorobenzoyl)azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1F RJJSKKUCLQTRSG-UHFFFAOYSA-N 0.000 claims description 5
- UUIIFJPBELOZOY-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-n-[2-(cyclopropylmethoxy)ethyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 UUIIFJPBELOZOY-UHFFFAOYSA-N 0.000 claims description 5
- ZSZKCQGINCBDRY-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 ZSZKCQGINCBDRY-UHFFFAOYSA-N 0.000 claims description 5
- BPTKXTADUFGFNW-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 BPTKXTADUFGFNW-UHFFFAOYSA-N 0.000 claims description 5
- RYBFAAMIVTZYPD-UHFFFAOYSA-N 2-[[1-(4-cyclohexylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1CCCCC1 RYBFAAMIVTZYPD-UHFFFAOYSA-N 0.000 claims description 5
- SWAXOTYPGIHXQI-UHFFFAOYSA-N 2-[[1-[4-(3,4-difluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C(F)=C1 SWAXOTYPGIHXQI-UHFFFAOYSA-N 0.000 claims description 5
- URJBPCAUBHEIMR-UHFFFAOYSA-N 2-[[1-[4-(3,4-dimethylphenyl)-2-fluorobenzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1C1=CC=C(C)C(C)=C1 URJBPCAUBHEIMR-UHFFFAOYSA-N 0.000 claims description 5
- ABPNUXWTZLMFCJ-UHFFFAOYSA-N 2-[[1-[4-(3-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC(F)=C1 ABPNUXWTZLMFCJ-UHFFFAOYSA-N 0.000 claims description 5
- DPAWGEMUUJQEFM-UHFFFAOYSA-N 2-[[1-[4-(4-chloro-2-methoxyphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1OC DPAWGEMUUJQEFM-UHFFFAOYSA-N 0.000 claims description 5
- FWNYWZFEIUSADZ-UHFFFAOYSA-N 2-[[1-[4-(4-fluoro-2-methoxyphenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound COC1=CC(F)=CC=C1C1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 FWNYWZFEIUSADZ-UHFFFAOYSA-N 0.000 claims description 5
- FNYCDMMUCUKKOD-UHFFFAOYSA-N 2-[[1-[4-(4-fluoro-2-methoxyphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1OC FNYCDMMUCUKKOD-UHFFFAOYSA-N 0.000 claims description 5
- TZGQIXCKBUIGMY-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 TZGQIXCKBUIGMY-UHFFFAOYSA-N 0.000 claims description 5
- MFHGESYXTSGQJJ-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 MFHGESYXTSGQJJ-UHFFFAOYSA-N 0.000 claims description 5
- UNGWJCMBVHTRLJ-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)-3-methylbenzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1C)=CC=C1C1=CC=C(F)C=C1 UNGWJCMBVHTRLJ-UHFFFAOYSA-N 0.000 claims description 5
- QVLQLTXZTFUQOM-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 QVLQLTXZTFUQOM-UHFFFAOYSA-N 0.000 claims description 5
- KMYXAMHRDSPHBI-UHFFFAOYSA-N 2-[[1-[4-(difluoromethoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC(F)F)C=C1 KMYXAMHRDSPHBI-UHFFFAOYSA-N 0.000 claims description 5
- HSVZXMWUEXURPH-UHFFFAOYSA-N 2-[[1-[4-[4-(2-cyanopropan-2-yl)phenyl]benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C(C)(C)C#N)C=C1 HSVZXMWUEXURPH-UHFFFAOYSA-N 0.000 claims description 5
- FTJISSHZEQNTPY-UHFFFAOYSA-N 2-[[1-[4-[4-(2-hydroxypropan-2-yl)phenyl]benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C(C)(C)O)C=C1 FTJISSHZEQNTPY-UHFFFAOYSA-N 0.000 claims description 5
- ZGGDFEKDZGZBQK-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 ZGGDFEKDZGZBQK-UHFFFAOYSA-N 0.000 claims description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 5
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- NAIKLJFRJWVSMS-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-[4-(4-methoxyphenyl)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(OC)C=C1 NAIKLJFRJWVSMS-UHFFFAOYSA-N 0.000 claims description 5
- NWZASWIYAWTBJQ-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-[4-(5-methoxypyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(OC)C=N1 NWZASWIYAWTBJQ-UHFFFAOYSA-N 0.000 claims description 5
- QWCQORGDYYALKY-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-[4-(6-methoxypyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=CC(OC)=N1 QWCQORGDYYALKY-UHFFFAOYSA-N 0.000 claims description 5
- LUMZRMNTOJGGJE-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(3-methyl-4-phenylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1C)=CC=C1C1=CC=CC=C1 LUMZRMNTOJGGJE-UHFFFAOYSA-N 0.000 claims description 5
- YUUBHRMPPOARBY-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(3-methyl-4-pyridin-3-ylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1C)=CC=C1C1=CC=CN=C1 YUUBHRMPPOARBY-UHFFFAOYSA-N 0.000 claims description 5
- YFNROXZXLXKHIP-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(3-methyl-4-pyridin-4-ylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1C)=CC=C1C1=CC=NC=C1 YFNROXZXLXKHIP-UHFFFAOYSA-N 0.000 claims description 5
- QHXDOYGRAWOZPP-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(6-methylpyridin-3-yl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C)N=C1 QHXDOYGRAWOZPP-UHFFFAOYSA-N 0.000 claims description 5
- SCBNWEUWIVBOMW-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(trifluoromethoxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 SCBNWEUWIVBOMW-UHFFFAOYSA-N 0.000 claims description 5
- NYRWYLAITAHVJO-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(trifluoromethylsulfanyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(SC(F)(F)F)C=C1 NYRWYLAITAHVJO-UHFFFAOYSA-N 0.000 claims description 5
- GXAPRGFPHDLVAD-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[2-(trifluoromethyl)pyrimidin-5-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CN=C(C(F)(F)F)N=C1 GXAPRGFPHDLVAD-UHFFFAOYSA-N 0.000 claims description 5
- DQIHZRIQSGZUNT-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenyl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C(F)(F)F)C=C1 DQIHZRIQSGZUNT-UHFFFAOYSA-N 0.000 claims description 5
- LPJYBXIGKTWZBE-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[5-(trifluoromethyl)pyridin-3-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CN=CC(C(F)(F)F)=C1 LPJYBXIGKTWZBE-UHFFFAOYSA-N 0.000 claims description 5
- JCYWSSAWRQTISG-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[6-(trifluoromethyl)pyridin-2-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=CC(C(F)(F)F)=N1 JCYWSSAWRQTISG-UHFFFAOYSA-N 0.000 claims description 5
- AYWZBTXIROYVHR-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-4-methyl-2-[[1-(4-methylbenzoyl)azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=CC(C)=CC=C1C(=O)N1CC(CN2N=C3C=CC(=C(C)C3=C2)C(=O)NCCOCC2CC2)C1 AYWZBTXIROYVHR-UHFFFAOYSA-N 0.000 claims description 5
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- 235000010215 titanium dioxide Nutrition 0.000 claims description 5
- GODWMTNJBWKHFT-UHFFFAOYSA-N 2-[[1-(2-fluoro-4-morpholin-4-ylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1N1CCOCC1 GODWMTNJBWKHFT-UHFFFAOYSA-N 0.000 claims description 4
- MGFAWXYJVHPALC-UHFFFAOYSA-N 2-[[1-(2-fluoro-4-pyrrolidin-1-ylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1N1CCCC1 MGFAWXYJVHPALC-UHFFFAOYSA-N 0.000 claims description 4
- OCLDFGXRQLQURK-UHFFFAOYSA-N 2-[[1-(3-chlorobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=CC(Cl)=C1 OCLDFGXRQLQURK-UHFFFAOYSA-N 0.000 claims description 4
- GDPFQCWAMCFJJG-UHFFFAOYSA-N 2-[[1-(3-fluoro-4-phenylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1F)=CC=C1C1=CC=CC=C1 GDPFQCWAMCFJJG-UHFFFAOYSA-N 0.000 claims description 4
- BPTKXTADUFGFNW-OQUUVRJDSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-N-[1,1,2,2-tetradeuterio-2-(trideuteriomethoxy)ethyl]indazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CCC(CC2)CN2N=C3C=CC(=C(C3=C2)C)C(=O)NC(C(OC([2H])([2H])[2H])([2H])[2H])([2H])[2H])C=C1 BPTKXTADUFGFNW-OQUUVRJDSA-N 0.000 claims description 4
- WPNALUNSUGDILL-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-(2-propan-2-yloxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 WPNALUNSUGDILL-UHFFFAOYSA-N 0.000 claims description 4
- RUZRUHHOVKILDQ-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 RUZRUHHOVKILDQ-UHFFFAOYSA-N 0.000 claims description 4
- QASBOOLNYXSVFO-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-[2-(trifluoromethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 QASBOOLNYXSVFO-UHFFFAOYSA-N 0.000 claims description 4
- MZOMPMCWALTLOD-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-[2-(cyclopropylmethoxy)ethyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 MZOMPMCWALTLOD-UHFFFAOYSA-N 0.000 claims description 4
- HHPMUSUISAECHR-UHFFFAOYSA-N 2-[[1-(4-cyclopropylbenzoyl)azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1C1CC1 HHPMUSUISAECHR-UHFFFAOYSA-N 0.000 claims description 4
- HTEMLHOAJRBIBZ-UHFFFAOYSA-N 2-[[1-(4-methoxybenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC)C=C1 HTEMLHOAJRBIBZ-UHFFFAOYSA-N 0.000 claims description 4
- BUTZUPRKKTURTD-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(2-fluoro-4-methoxyphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1C1=CC=C(OC)C=C1F BUTZUPRKKTURTD-UHFFFAOYSA-N 0.000 claims description 4
- VVVWNIOLQSRSHR-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(4-methoxyphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1C1=CC=C(OC)C=C1 VVVWNIOLQSRSHR-UHFFFAOYSA-N 0.000 claims description 4
- YZOZTYADAIGIGU-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(4-methylphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1C1=CC=C(C)C=C1 YZOZTYADAIGIGU-UHFFFAOYSA-N 0.000 claims description 4
- LGJPNXHZTQGZIL-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C=C1F LGJPNXHZTQGZIL-UHFFFAOYSA-N 0.000 claims description 4
- RZICSYGTCPTWCH-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-[2-(trifluoromethoxy)phenyl]benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1C1=CC=CC=C1OC(F)(F)F RZICSYGTCPTWCH-UHFFFAOYSA-N 0.000 claims description 4
- VCSGALNQAXUAKT-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-[3-(trifluoromethyl)phenyl]benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1C1=CC=CC(C(F)(F)F)=C1 VCSGALNQAXUAKT-UHFFFAOYSA-N 0.000 claims description 4
- UDQSQMLHEBRMRM-UHFFFAOYSA-N 2-[[1-[4-(2,4-difluorophenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1F UDQSQMLHEBRMRM-UHFFFAOYSA-N 0.000 claims description 4
- DXLOBYOAAYKOSY-UHFFFAOYSA-N 2-[[1-[4-(2-chloro-4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1Cl DXLOBYOAAYKOSY-UHFFFAOYSA-N 0.000 claims description 4
- CUMHUWBPYFVGEG-UHFFFAOYSA-N 2-[[1-[4-(2-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC=C1F CUMHUWBPYFVGEG-UHFFFAOYSA-N 0.000 claims description 4
- MCIMTZWPHQATMR-UHFFFAOYSA-N 2-[[1-[4-(3-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC(F)=C1 MCIMTZWPHQATMR-UHFFFAOYSA-N 0.000 claims description 4
- LJVUHXBUZWAZLV-UHFFFAOYSA-N 2-[[1-[4-(4-chloro-2-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1F LJVUHXBUZWAZLV-UHFFFAOYSA-N 0.000 claims description 4
- GBBPIWXDSCWCPW-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2-propan-2-yloxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 GBBPIWXDSCWCPW-UHFFFAOYSA-N 0.000 claims description 4
- LQCOGGLGKPBQDS-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 LQCOGGLGKPBQDS-UHFFFAOYSA-N 0.000 claims description 4
- GHFPMPVGUQNABK-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-[2-(trifluoromethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 GHFPMPVGUQNABK-UHFFFAOYSA-N 0.000 claims description 4
- NPAOFNKDAOWCBA-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-[2-(trifluoromethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 NPAOFNKDAOWCBA-UHFFFAOYSA-N 0.000 claims description 4
- RWBHZPBVBLPMOY-UHFFFAOYSA-N 2-[[1-[4-(4-methoxy-2-methylphenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound CC1=CC(OC)=CC=C1C1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 RWBHZPBVBLPMOY-UHFFFAOYSA-N 0.000 claims description 4
- QEMNCVZLFUEUEI-UHFFFAOYSA-N 2-[[1-[4-(5-chloropyridin-2-yl)oxybenzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(Cl)C=N1 QEMNCVZLFUEUEI-UHFFFAOYSA-N 0.000 claims description 4
- VHCIOUPQYSNNCM-UHFFFAOYSA-N 4-methyl-2-[[1-(4-methylbenzoyl)piperidin-4-yl]methyl]-n-(2-propan-2-yloxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C)C=C1 VHCIOUPQYSNNCM-UHFFFAOYSA-N 0.000 claims description 4
- RDVIXKRBAMMRQV-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[3-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 RDVIXKRBAMMRQV-UHFFFAOYSA-N 0.000 claims description 4
- MLFBLGJKMMDFSU-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 MLFBLGJKMMDFSU-UHFFFAOYSA-N 0.000 claims description 4
- NVKFXOCQIJVWCW-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[4-(trifluoromethyl)phenyl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C(F)(F)F)C=C1 NVKFXOCQIJVWCW-UHFFFAOYSA-N 0.000 claims description 4
- XHBMWWOUHJMMOR-UHFFFAOYSA-N 4-methyl-n-(2-propan-2-yloxyethyl)-2-[[1-[4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C=C1 XHBMWWOUHJMMOR-UHFFFAOYSA-N 0.000 claims description 4
- 239000004229 Alkannin Substances 0.000 claims description 4
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 claims description 4
- WOXNTJUTOFEMST-UHFFFAOYSA-N CN1N=C2C=CC(=CC2=C1)C(=O)N Chemical compound CN1N=C2C=CC(=CC2=C1)C(=O)N WOXNTJUTOFEMST-UHFFFAOYSA-N 0.000 claims description 4
- 239000004214 Fast Green FCF Substances 0.000 claims description 4
- 239000004230 Fast Yellow AB Substances 0.000 claims description 4
- 239000004218 Orcein Substances 0.000 claims description 4
- 239000004236 Ponceau SX Substances 0.000 claims description 4
- 239000004283 Sodium sorbate Substances 0.000 claims description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000004234 Yellow 2G Substances 0.000 claims description 4
- 235000019232 alkannin Nutrition 0.000 claims description 4
- 239000004411 aluminium Substances 0.000 claims description 4
- 235000010210 aluminium Nutrition 0.000 claims description 4
- 239000001654 beetroot red Substances 0.000 claims description 4
- 235000012677 beetroot red Nutrition 0.000 claims description 4
- 239000004109 brown FK Substances 0.000 claims description 4
- 235000012713 brown FK Nutrition 0.000 claims description 4
- 239000001678 brown HT Substances 0.000 claims description 4
- 235000012670 brown HT Nutrition 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 235000010216 calcium carbonate Nutrition 0.000 claims description 4
- 239000004303 calcium sorbate Substances 0.000 claims description 4
- 150000003857 carboxamides Chemical class 0.000 claims description 4
- 239000004121 copper complexes of chlorophylls and chlorophyllins Substances 0.000 claims description 4
- 235000012700 copper complexes of chlorophylls and chlorophyllins Nutrition 0.000 claims description 4
- 235000019240 fast green FCF Nutrition 0.000 claims description 4
- 235000019233 fast yellow AB Nutrition 0.000 claims description 4
- 235000010193 gold Nutrition 0.000 claims description 4
- 239000004333 gold (food color) Substances 0.000 claims description 4
- 239000004179 indigotine Substances 0.000 claims description 4
- 235000012738 indigotine Nutrition 0.000 claims description 4
- 235000010213 iron oxides and hydroxides Nutrition 0.000 claims description 4
- 239000004407 iron oxides and hydroxides Substances 0.000 claims description 4
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004335 litholrubine BK Substances 0.000 claims description 4
- 235000010187 litholrubine BK Nutrition 0.000 claims description 4
- REBVHHBQKUPYDY-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(3-methylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=CC(C)=C1 REBVHHBQKUPYDY-UHFFFAOYSA-N 0.000 claims description 4
- KPWKSERWIUWEOW-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-methylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C)C=C1 KPWKSERWIUWEOW-UHFFFAOYSA-N 0.000 claims description 4
- FSRKZOGTAIHQTL-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(2-methylphenyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=CC=C1C FSRKZOGTAIHQTL-UHFFFAOYSA-N 0.000 claims description 4
- NCGGHDSUGWCTEX-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(trifluoromethylsulfanyl)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(SC(F)(F)F)C=C1 NCGGHDSUGWCTEX-UHFFFAOYSA-N 0.000 claims description 4
- LYCAUZISTSYOHP-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(trifluoromethylsulfonyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 LYCAUZISTSYOHP-UHFFFAOYSA-N 0.000 claims description 4
- BEDIXNRQLXUNRY-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[6-(trifluoromethyl)pyridin-3-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C(F)(F)F)N=C1 BEDIXNRQLXUNRY-UHFFFAOYSA-N 0.000 claims description 4
- KSZCSGYIHDYJKW-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-2-[[1-[4-(4-fluorophenoxy)benzoyl]azetidin-3-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 KSZCSGYIHDYJKW-UHFFFAOYSA-N 0.000 claims description 4
- LDFNFBQEENXQGW-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 LDFNFBQEENXQGW-UHFFFAOYSA-N 0.000 claims description 4
- BQJWCBMADUELHX-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-4-methyl-2-[[1-(4-methylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=CC(C)=CC=C1C(=O)N1CCC(CN2N=C3C=CC(=C(C)C3=C2)C(=O)NCCOCC2CC2)CC1 BQJWCBMADUELHX-UHFFFAOYSA-N 0.000 claims description 4
- 235000019248 orcein Nutrition 0.000 claims description 4
- 239000004177 patent blue V Substances 0.000 claims description 4
- 235000012736 patent blue V Nutrition 0.000 claims description 4
- 235000019237 ponceau SX Nutrition 0.000 claims description 4
- 239000004302 potassium sorbate Substances 0.000 claims description 4
- 239000004172 quinoline yellow Substances 0.000 claims description 4
- 235000012752 quinoline yellow Nutrition 0.000 claims description 4
- 239000004180 red 2G Substances 0.000 claims description 4
- 235000012739 red 2G Nutrition 0.000 claims description 4
- 239000002151 riboflavin Substances 0.000 claims description 4
- 235000019192 riboflavin Nutrition 0.000 claims description 4
- 239000004248 saffron Substances 0.000 claims description 4
- 235000013974 saffron Nutrition 0.000 claims description 4
- 239000004332 silver Substances 0.000 claims description 4
- 235000010191 silver Nutrition 0.000 claims description 4
- 239000004334 sorbic acid Substances 0.000 claims description 4
- 239000004149 tartrazine Substances 0.000 claims description 4
- 235000012756 tartrazine Nutrition 0.000 claims description 4
- 239000004108 vegetable carbon Substances 0.000 claims description 4
- 235000012712 vegetable carbon Nutrition 0.000 claims description 4
- 235000019235 yellow 2G Nutrition 0.000 claims description 4
- KGGVSDFFFLBNFC-UHFFFAOYSA-N 2-[[1-(4-bromo-2-fluorobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Br)C=C1F KGGVSDFFFLBNFC-UHFFFAOYSA-N 0.000 claims description 3
- CEBPMNZONLVAPQ-UHFFFAOYSA-N 2-[[1-(4-bromobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Br)C=C1 CEBPMNZONLVAPQ-UHFFFAOYSA-N 0.000 claims description 3
- AZGJJEMQMOERRJ-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)(C)C)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 AZGJJEMQMOERRJ-UHFFFAOYSA-N 0.000 claims description 3
- PIRVDDFDENBOJG-UHFFFAOYSA-N 2-[[1-(4-cyanobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C#N)C=C1 PIRVDDFDENBOJG-UHFFFAOYSA-N 0.000 claims description 3
- RJDDRRLXTSDDAQ-UHFFFAOYSA-N 2-[[1-(4-cyclopropylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1CC1 RJDDRRLXTSDDAQ-UHFFFAOYSA-N 0.000 claims description 3
- XDOKZIYPLCIKEY-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C(=C1)F)=CC=C1C1=CC=C(F)C=C1 XDOKZIYPLCIKEY-UHFFFAOYSA-N 0.000 claims description 3
- JUQSIDMOHDSGOZ-UHFFFAOYSA-N 2-[[1-[4-(2,4-difluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1F JUQSIDMOHDSGOZ-UHFFFAOYSA-N 0.000 claims description 3
- GCSLZWXTMMEERK-UHFFFAOYSA-N 2-[[1-[4-(3,4-difluorophenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C(F)=C1 GCSLZWXTMMEERK-UHFFFAOYSA-N 0.000 claims description 3
- SYUDBYOVJIPXGS-UHFFFAOYSA-N 2-[[1-[4-(4-chlorophenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(Cl)C=C1 SYUDBYOVJIPXGS-UHFFFAOYSA-N 0.000 claims description 3
- JHDJDABGIMUFHB-UHFFFAOYSA-N 2-[[1-[4-(4-cyanophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C#N)C=C1 JHDJDABGIMUFHB-UHFFFAOYSA-N 0.000 claims description 3
- MFHGESYXTSGQJJ-PMZDYHOHSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-N-[1,1,2,2-tetradeuterio-2-(trideuteriomethoxy)ethyl]indazole-5-carboxamide Chemical compound FC1=CC=C(OC2=CC=C(C(=O)N3CCC(CC3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NC(C(OC([2H])([2H])[2H])([2H])[2H])([2H])[2H])C=C2)C=C1 MFHGESYXTSGQJJ-PMZDYHOHSA-N 0.000 claims description 3
- WMPZVKJAXFEXMT-UHFFFAOYSA-N 2-[[1-[4-(4-tert-butylphenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(C)(C)C)C=C1 WMPZVKJAXFEXMT-UHFFFAOYSA-N 0.000 claims description 3
- GNDCZNWVVLGLEJ-UHFFFAOYSA-N 2-[[1-[4-(5-cyanopyridin-2-yl)oxybenzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C#N)C=N1 GNDCZNWVVLGLEJ-UHFFFAOYSA-N 0.000 claims description 3
- FLMSWAVVHPZMEI-UHFFFAOYSA-N 2-[[1-[4-(6-methoxypyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound COC1=CC=CC(C=2C=CC(=CC=2)C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)=N1 FLMSWAVVHPZMEI-UHFFFAOYSA-N 0.000 claims description 3
- NYCNWXAXQJPPAQ-UHFFFAOYSA-N 4-methyl-1H-indazole-5-carboxamide Chemical compound Cc1c(ccc2n[nH]cc12)C(N)=O NYCNWXAXQJPPAQ-UHFFFAOYSA-N 0.000 claims description 3
- CWZYTFYCLNKNFZ-UHFFFAOYSA-N 4-methyl-2-[[1-[4-(2-methylpyrimidin-5-yl)benzoyl]piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=NC(C)=NC=C1C1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 CWZYTFYCLNKNFZ-UHFFFAOYSA-N 0.000 claims description 3
- DYPDCHOFDCWEFJ-UHFFFAOYSA-N 4-methyl-2-[[1-[4-(4-methylphenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=CC(C)=CC=C1OC1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 DYPDCHOFDCWEFJ-UHFFFAOYSA-N 0.000 claims description 3
- COIQBTRCBSCGDU-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-(trifluoromethoxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 COIQBTRCBSCGDU-UHFFFAOYSA-N 0.000 claims description 3
- BNFWKSPKZULUKU-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[5-(trifluoromethyl)pyridin-2-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C(F)(F)F)C=N1 BNFWKSPKZULUKU-UHFFFAOYSA-N 0.000 claims description 3
- QSECCOHSDUBPRA-UHFFFAOYSA-N 4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 QSECCOHSDUBPRA-UHFFFAOYSA-N 0.000 claims description 3
- VYPGUGHGRUXEIV-UHFFFAOYSA-N 4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 VYPGUGHGRUXEIV-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000004148 curcumin Substances 0.000 claims description 3
- 235000012754 curcumin Nutrition 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 125000000623 heterocyclic group Chemical group 0.000 claims description 3
- ZKUJKGXQYXUMGJ-UHFFFAOYSA-N n-(2-cyclobutyloxyethyl)-4-methyl-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC3CCC3)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 ZKUJKGXQYXUMGJ-UHFFFAOYSA-N 0.000 claims description 3
- NPVVTIIEENAAQB-UHFFFAOYSA-N n-(2-cyclopropyloxyethyl)-4-methyl-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC3CC3)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 NPVVTIIEENAAQB-UHFFFAOYSA-N 0.000 claims description 3
- WSWPUNIQBHZFAA-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-[4-(4-methoxy-2-methylphenyl)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(OC)C=C1C WSWPUNIQBHZFAA-UHFFFAOYSA-N 0.000 claims description 3
- FXNXSOIAPVRFMQ-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-[4-(4-methoxyphenoxy)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(OC)C=C1 FXNXSOIAPVRFMQ-UHFFFAOYSA-N 0.000 claims description 3
- HAGOCRAWVATLLV-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-phenoxybenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC=C1 HAGOCRAWVATLLV-UHFFFAOYSA-N 0.000 claims description 3
- VIYFYEQVUWIPSV-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(2-methylpyrimidin-5-yl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CN=C(C)N=C1 VIYFYEQVUWIPSV-UHFFFAOYSA-N 0.000 claims description 3
- UNOIGIKLDPXDSX-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[3-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=C1 UNOIGIKLDPXDSX-UHFFFAOYSA-N 0.000 claims description 3
- VZDARLVOIYTWEF-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 VZDARLVOIYTWEF-UHFFFAOYSA-N 0.000 claims description 3
- DVGALJSPRLZYPH-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-2-[[1-[4-(4-fluorophenyl)benzoyl]azetidin-3-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 DVGALJSPRLZYPH-UHFFFAOYSA-N 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- YXEPSMGUGBXJOF-UHFFFAOYSA-N 2-[[1-(2-methoxybenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=CC=C1OC YXEPSMGUGBXJOF-UHFFFAOYSA-N 0.000 claims description 2
- OKCLEHUXLBYNJQ-UHFFFAOYSA-N 2-[[1-(4-bromobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Br)C=C1 OKCLEHUXLBYNJQ-UHFFFAOYSA-N 0.000 claims description 2
- UBRYYUONWKIKFK-UHFFFAOYSA-N 2-[[1-(4-cyclopropylbenzoyl)piperidin-4-yl]methyl]-n-[2-(cyclopropylmethoxy)ethyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1CC1 UBRYYUONWKIKFK-UHFFFAOYSA-N 0.000 claims description 2
- RFTJTYAMOYJILP-UHFFFAOYSA-N 2-[[1-(4-imidazol-1-ylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1N1C=CN=C1 RFTJTYAMOYJILP-UHFFFAOYSA-N 0.000 claims description 2
- AOQSQDCNSVZICG-UHFFFAOYSA-N 2-[[1-[4-(5-chloropyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(Cl)C=N1 AOQSQDCNSVZICG-UHFFFAOYSA-N 0.000 claims description 2
- SGZHSIHJSGWVKR-UHFFFAOYSA-N 2-[[1-[4-(5-chloropyridin-2-yl)oxybenzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(Cl)C=N1 SGZHSIHJSGWVKR-UHFFFAOYSA-N 0.000 claims description 2
- XWKPUOWWYFQQPR-UHFFFAOYSA-N 2-[[1-[4-(5-cyanopyridin-2-yl)oxybenzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C#N)C=N1 XWKPUOWWYFQQPR-UHFFFAOYSA-N 0.000 claims description 2
- YFLBHRJAFCCQNN-UHFFFAOYSA-N 2-[[1-[4-(5-methoxypyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound N1=CC(OC)=CC=C1C1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 YFLBHRJAFCCQNN-UHFFFAOYSA-N 0.000 claims description 2
- RNSOYWJBOPUXHN-UHFFFAOYSA-N 2-[[1-[4-(difluoromethyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)F)C=C1 RNSOYWJBOPUXHN-UHFFFAOYSA-N 0.000 claims description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- PPLDMTGDNKDMFC-UHFFFAOYSA-N 4-methyl-N-(2,2,2-trifluoroethyl)-2-[[1-[4-[6-(trifluoromethyl)pyridin-2-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)-c3cccc(n3)C(F)(F)F)cc12)C(=O)NCC(F)(F)F PPLDMTGDNKDMFC-UHFFFAOYSA-N 0.000 claims description 2
- AITZZBZYTRBXQP-UHFFFAOYSA-N 4-methyl-N-(2,2,2-trifluoroethyl)-2-[[1-[4-[6-(trifluoromethyl)pyridin-3-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)-c3ccc(nc3)C(F)(F)F)cc12)C(=O)NCC(F)(F)F AITZZBZYTRBXQP-UHFFFAOYSA-N 0.000 claims description 2
- NEEDQBULYJZQNK-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 NEEDQBULYJZQNK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004215 Carbon black (E152) Substances 0.000 claims description 2
- 239000004233 Indanthrene blue RS Substances 0.000 claims description 2
- 239000004231 Riboflavin-5-Sodium Phosphate Substances 0.000 claims description 2
- 239000004191 allura red AC Substances 0.000 claims description 2
- 235000012741 allura red AC Nutrition 0.000 claims description 2
- 239000004178 amaranth Substances 0.000 claims description 2
- 235000012735 amaranth Nutrition 0.000 claims description 2
- 239000004176 azorubin Substances 0.000 claims description 2
- 235000012733 azorubine Nutrition 0.000 claims description 2
- 239000004126 brilliant black BN Substances 0.000 claims description 2
- 235000012709 brilliant black BN Nutrition 0.000 claims description 2
- 239000004161 brilliant blue FCF Substances 0.000 claims description 2
- 235000012745 brilliant blue FCF Nutrition 0.000 claims description 2
- 235000019241 carbon black Nutrition 0.000 claims description 2
- 239000004106 carminic acid Substances 0.000 claims description 2
- 235000012730 carminic acid Nutrition 0.000 claims description 2
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 claims description 2
- 235000012698 chlorophylls and chlorophyllins Nutrition 0.000 claims description 2
- 239000001679 citrus red 2 Substances 0.000 claims description 2
- 235000013986 citrus red 2 Nutrition 0.000 claims description 2
- 230000002500 effect on skin Effects 0.000 claims description 2
- 239000004120 green S Substances 0.000 claims description 2
- 235000012701 green S Nutrition 0.000 claims description 2
- 235000019239 indanthrene blue RS Nutrition 0.000 claims description 2
- CVQUHPXABRUWGC-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(4-methylphenoxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C)C=C1 CVQUHPXABRUWGC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004175 ponceau 4R Substances 0.000 claims description 2
- 235000012731 ponceau 4R Nutrition 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 claims description 2
- 235000019234 riboflavin-5-sodium phosphate Nutrition 0.000 claims description 2
- 125000002999 4-(trifluoromethyl)benzoyl group Chemical group FC(C1=CC=C(C(=O)*)C=C1)(F)F 0.000 claims 6
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- 125000002981 3-(trifluoromethyl)benzoyl group Chemical group FC(C=1C=C(C(=O)*)C=CC1)(F)F 0.000 claims 2
- MVZKSPJKFFUQPV-UHFFFAOYSA-N 4-methyl-n-[2-(trifluoromethoxy)ethyl]-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 MVZKSPJKFFUQPV-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 239000001922 Gum ghatti Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000003054 hormonal effect Effects 0.000 abstract description 21
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 abstract description 17
- 150000001875 compounds Chemical class 0.000 description 781
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 342
- 238000005481 NMR spectroscopy Methods 0.000 description 268
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 247
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 183
- 238000005160 1H NMR spectroscopy Methods 0.000 description 166
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 126
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 90
- 238000000746 purification Methods 0.000 description 76
- 102100024448 Prostaglandin E2 receptor EP2 subtype Human genes 0.000 description 74
- 150000001412 amines Chemical class 0.000 description 67
- 239000000243 solution Substances 0.000 description 65
- 239000007858 starting material Substances 0.000 description 62
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 55
- 239000011541 reaction mixture Substances 0.000 description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 48
- 238000004296 chiral HPLC Methods 0.000 description 47
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 46
- 241001465754 Metazoa Species 0.000 description 46
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 46
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 44
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
- 238000001514 detection method Methods 0.000 description 39
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 37
- 238000006243 chemical reaction Methods 0.000 description 37
- 0 Cc1ccc(C(C2*CCC(CCN3C=C(C(C)=C(C=C4)C(NCCOC)=O)C4=CC*3)CCC2)=O)c(F)c1 Chemical compound Cc1ccc(C(C2*CCC(CCN3C=C(C(C)=C(C=C4)C(NCCOC)=O)C4=CC*3)CCC2)=O)c(F)c1 0.000 description 36
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 36
- 238000010992 reflux Methods 0.000 description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 32
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 32
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 31
- 239000012074 organic phase Substances 0.000 description 31
- 239000002904 solvent Substances 0.000 description 31
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 30
- 229910052938 sodium sulfate Inorganic materials 0.000 description 30
- 235000011152 sodium sulphate Nutrition 0.000 description 30
- 150000001408 amides Chemical class 0.000 description 29
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 29
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 27
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 27
- 230000000694 effects Effects 0.000 description 25
- 239000003826 tablet Substances 0.000 description 25
- 239000005711 Benzoic acid Substances 0.000 description 24
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
- 101150041968 CDC13 gene Proteins 0.000 description 22
- 235000010233 benzoic acid Nutrition 0.000 description 22
- 238000004440 column chromatography Methods 0.000 description 21
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 20
- 229960004400 levonorgestrel Drugs 0.000 description 20
- 238000011287 therapeutic dose Methods 0.000 description 20
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- 230000016087 ovulation Effects 0.000 description 17
- LXWNTLBMNCXRQN-UHFFFAOYSA-N 4'-fluoro-1,1'-biphenyl-4-carboxylic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(F)C=C1 LXWNTLBMNCXRQN-UHFFFAOYSA-N 0.000 description 16
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 16
- 150000002148 esters Chemical class 0.000 description 16
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 15
- 239000000460 chlorine Substances 0.000 description 15
- 238000002347 injection Methods 0.000 description 15
- 239000007924 injection Substances 0.000 description 15
- 239000000741 silica gel Substances 0.000 description 15
- 229910002027 silica gel Inorganic materials 0.000 description 15
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 14
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 14
- 229910002091 carbon monoxide Inorganic materials 0.000 description 14
- YYKALFXKRWCSLY-UHFFFAOYSA-N 4-(4-fluorophenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(F)C=C1 YYKALFXKRWCSLY-UHFFFAOYSA-N 0.000 description 13
- XRHGYUZYPHTUJZ-UHFFFAOYSA-N 4-chlorobenzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1 XRHGYUZYPHTUJZ-UHFFFAOYSA-N 0.000 description 13
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 13
- 230000002254 contraceptive effect Effects 0.000 description 13
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 12
- 241000700159 Rattus Species 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 12
- 238000011121 vaginal smear Methods 0.000 description 12
- 102000009151 Luteinizing Hormone Human genes 0.000 description 11
- 108010073521 Luteinizing Hormone Proteins 0.000 description 11
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 11
- 239000012043 crude product Substances 0.000 description 11
- 229960002986 dinoprostone Drugs 0.000 description 11
- 229910052750 molybdenum Inorganic materials 0.000 description 11
- 239000011733 molybdenum Substances 0.000 description 11
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 11
- 238000011282 treatment Methods 0.000 description 11
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 10
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 10
- 229910000024 caesium carbonate Inorganic materials 0.000 description 10
- 230000004720 fertilization Effects 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 229940040129 luteinizing hormone Drugs 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 9
- 230000008485 antagonism Effects 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 9
- 150000001735 carboxylic acids Chemical class 0.000 description 9
- 238000004587 chromatography analysis Methods 0.000 description 9
- 239000003433 contraceptive agent Substances 0.000 description 9
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 9
- 238000001727 in vivo Methods 0.000 description 9
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 9
- 230000013011 mating Effects 0.000 description 9
- 230000035935 pregnancy Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- VWGJFGJEXBXEDJ-UHFFFAOYSA-P acetic acid;(2-methanidylphenyl)-bis(2-methylphenyl)phosphanium;palladium Chemical compound [Pd].[Pd].CC(O)=O.CC(O)=O.CC1=CC=CC=C1[PH+](C=1C(=CC=CC=1)[CH2-])C1=CC=CC=C1C.CC1=CC=CC=C1[PH+](C=1C(=CC=CC=1)[CH2-])C1=CC=CC=C1C VWGJFGJEXBXEDJ-UHFFFAOYSA-P 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 210000000287 oocyte Anatomy 0.000 description 8
- 150000003180 prostaglandins Chemical class 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 102000005962 receptors Human genes 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 239000003643 water by type Substances 0.000 description 8
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 description 7
- ZXKKOFJYPRJFIE-UHFFFAOYSA-N 4-(trifluoromethoxy)benzoyl chloride Chemical compound FC(F)(F)OC1=CC=C(C(Cl)=O)C=C1 ZXKKOFJYPRJFIE-UHFFFAOYSA-N 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 7
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 7
- 239000011737 fluorine Substances 0.000 description 7
- 229910052731 fluorine Inorganic materials 0.000 description 7
- XBAKPVXSYYYKPT-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 XBAKPVXSYYYKPT-UHFFFAOYSA-N 0.000 description 7
- 230000000624 ovulatory effect Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 210000001771 cumulus cell Anatomy 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 125000001153 fluoro group Chemical group F* 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 6
- 239000012453 solvate Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- DARTVAOOTJKHQW-UHFFFAOYSA-N tert-butyl 4-[(4-methylphenyl)sulfonyloxymethyl]piperidine-1-carboxylate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1CCN(C(=O)OC(C)(C)C)CC1 DARTVAOOTJKHQW-UHFFFAOYSA-N 0.000 description 6
- OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 6
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 5
- HVRCLXXJIQTXHC-UHFFFAOYSA-N 1-methylindole-3-carboxylic acid Chemical compound C1=CC=C2N(C)C=C(C(O)=O)C2=C1 HVRCLXXJIQTXHC-UHFFFAOYSA-N 0.000 description 5
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 description 5
- OOAHPLWBUUTFMV-UHFFFAOYSA-N 2-fluoro-4-(trifluoromethyl)benzoyl chloride Chemical compound FC1=CC(C(F)(F)F)=CC=C1C(Cl)=O OOAHPLWBUUTFMV-UHFFFAOYSA-N 0.000 description 5
- CCNGYKFALZVXHZ-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 CCNGYKFALZVXHZ-UHFFFAOYSA-N 0.000 description 5
- 239000007821 HATU Substances 0.000 description 5
- 208000031271 Unwanted pregnancy Diseases 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 238000011813 knockout mouse model Methods 0.000 description 5
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 5
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 229960000499 ulipristal acetate Drugs 0.000 description 5
- KIPSRYDSZQRPEA-UHFFFAOYSA-N 2,2,2-trifluoroethanamine Chemical compound NCC(F)(F)F KIPSRYDSZQRPEA-UHFFFAOYSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical class NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 4
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 4
- HTKXRTUKPXEALT-UHFFFAOYSA-N 3-bromo-2h-indazole Chemical class C1=CC=CC2=C(Br)NN=C21 HTKXRTUKPXEALT-UHFFFAOYSA-N 0.000 description 4
- KNXWKVQRYPQFOT-UHFFFAOYSA-N 4-(pentafluoro-$l^{6}-sulfanyl)benzoic acid Chemical compound OC(=O)C1=CC=C(S(F)(F)(F)(F)F)C=C1 KNXWKVQRYPQFOT-UHFFFAOYSA-N 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- QLQQQEUHPBMUCF-UHFFFAOYSA-N 5-bromo-4-methyl-1h-indazole Chemical compound CC1=C(Br)C=CC2=C1C=NN2 QLQQQEUHPBMUCF-UHFFFAOYSA-N 0.000 description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 102000008866 Prostaglandin E receptors Human genes 0.000 description 4
- 108010088540 Prostaglandin E receptors Proteins 0.000 description 4
- KVVMXWRFYAGASO-UHFFFAOYSA-N azetidine-1-carboxylic acid Chemical compound OC(=O)N1CCC1 KVVMXWRFYAGASO-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 231100000673 dose–response relationship Toxicity 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 239000000583 progesterone congener Substances 0.000 description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- BYWZHBHLUWHUKI-UHFFFAOYSA-N tert-butyl 3-[(4-methylphenyl)sulfonyloxymethyl]azetidine-1-carboxylate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1CN(C(=O)OC(C)(C)C)C1 BYWZHBHLUWHUKI-UHFFFAOYSA-N 0.000 description 4
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 4
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 4
- ADJBXDCXYMCCAD-UHFFFAOYSA-N (4-fluoro-2-methoxyphenyl)boronic acid Chemical compound COC1=CC(F)=CC=C1B(O)O ADJBXDCXYMCCAD-UHFFFAOYSA-N 0.000 description 3
- LBIOMKUSKYNSCF-UHFFFAOYSA-N 2-(3,3-difluoropyrrolidin-1-yl)ethanamine Chemical compound NCCN1CCC(F)(F)C1 LBIOMKUSKYNSCF-UHFFFAOYSA-N 0.000 description 3
- MYMMBUAADVNCAM-UHFFFAOYSA-N 2-[[1-(2-fluoro-4-methoxybenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC)C=C1F MYMMBUAADVNCAM-UHFFFAOYSA-N 0.000 description 3
- LWFMRYXVQLYSSI-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methyl-n-[2-(trifluoromethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 LWFMRYXVQLYSSI-UHFFFAOYSA-N 0.000 description 3
- WTFKLVMCPZBMMG-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(C(F)(F)F)C=C1F WTFKLVMCPZBMMG-UHFFFAOYSA-N 0.000 description 3
- WSQPCMKAIBMUNA-UHFFFAOYSA-N 2-[[1-[3-fluoro-4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(C(F)(F)F)C(F)=C1 WSQPCMKAIBMUNA-UHFFFAOYSA-N 0.000 description 3
- SXIHWHVYRYIZMU-UHFFFAOYSA-N 2-[[1-[4-(4-chloro-2-methylphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(Cl)C=C1C SXIHWHVYRYIZMU-UHFFFAOYSA-N 0.000 description 3
- GJGGAWHEOYWTMZ-UHFFFAOYSA-N 2-[[1-[4-(4-chlorophenoxy)benzoyl]azetidin-3-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(Cl)C=C1 GJGGAWHEOYWTMZ-UHFFFAOYSA-N 0.000 description 3
- XDFUQAJJGWMQBT-UHFFFAOYSA-N 2-[[1-[4-(4-cyanophenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C#N)C=C1 XDFUQAJJGWMQBT-UHFFFAOYSA-N 0.000 description 3
- ZXUAALZSYWYJJS-UHFFFAOYSA-N 2-[[1-[4-(4-fluoro-2-methylphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1C ZXUAALZSYWYJJS-UHFFFAOYSA-N 0.000 description 3
- HKXRXCBUDVRISK-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 HKXRXCBUDVRISK-UHFFFAOYSA-N 0.000 description 3
- OCIYTBZXTFPSPI-UHFFFAOYSA-N 2-fluoro-4-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=C(C(F)(F)F)C=C1F OCIYTBZXTFPSPI-UHFFFAOYSA-N 0.000 description 3
- AMYYUKGKCJKCBI-UHFFFAOYSA-N 2-methylsulfonylethanamine;hydrochloride Chemical compound Cl.CS(=O)(=O)CCN AMYYUKGKCJKCBI-UHFFFAOYSA-N 0.000 description 3
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- YVVCMTFJWOYNJW-UHFFFAOYSA-N 4-(4-chlorophenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(Cl)C=C1 YVVCMTFJWOYNJW-UHFFFAOYSA-N 0.000 description 3
- GJCRWEAWEDESNZ-UHFFFAOYSA-N 4-cyclopropylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1CC1 GJCRWEAWEDESNZ-UHFFFAOYSA-N 0.000 description 3
- LLXOLOGXJGMYJZ-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 LLXOLOGXJGMYJZ-UHFFFAOYSA-N 0.000 description 3
- QZTUSWLQGRIPID-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[6-(trifluoromethyl)pyridin-3-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 QZTUSWLQGRIPID-UHFFFAOYSA-N 0.000 description 3
- ZOPXUHDPGGHISS-UHFFFAOYSA-N 5-fluoro-1-methylindole-2-carboxylic acid Chemical compound FC1=CC=C2N(C)C(C(O)=O)=CC2=C1 ZOPXUHDPGGHISS-UHFFFAOYSA-N 0.000 description 3
- PLXRUBZTKAYNKQ-UHFFFAOYSA-N 5-methoxy-1-methylindole-2-carboxylic acid Chemical compound COC1=CC=C2N(C)C(C(O)=O)=CC2=C1 PLXRUBZTKAYNKQ-UHFFFAOYSA-N 0.000 description 3
- KXACSDHQSUBYNG-UHFFFAOYSA-N 6-methoxy-1-methylindole-2-carboxylic acid Chemical compound COC1=CC=C2C=C(C(O)=O)N(C)C2=C1 KXACSDHQSUBYNG-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 3
- 150000008061 acetanilides Chemical class 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 102000030621 adenylate cyclase Human genes 0.000 description 3
- 108060000200 adenylate cyclase Proteins 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 229960002903 benzyl benzoate Drugs 0.000 description 3
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 230000006037 cell lysis Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- NXQGGXCHGDYOHB-UHFFFAOYSA-L cyclopenta-1,4-dien-1-yl(diphenyl)phosphane;dichloropalladium;iron(2+) Chemical compound [Fe+2].Cl[Pd]Cl.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1.[CH-]1C=CC(P(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 NXQGGXCHGDYOHB-UHFFFAOYSA-L 0.000 description 3
- 125000004786 difluoromethoxy group Chemical group [H]C(F)(F)O* 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 125000001475 halogen functional group Chemical group 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 208000000509 infertility Diseases 0.000 description 3
- 238000007912 intraperitoneal administration Methods 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 230000005923 long-lasting effect Effects 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000012139 lysis buffer Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- VZJKOLSSOFXMDF-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-[4-(6-methoxypyridin-3-yl)benzoyl]piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(OC)N=C1 VZJKOLSSOFXMDF-UHFFFAOYSA-N 0.000 description 3
- BJCHTDKEHZNQIT-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-pyridin-2-yloxybenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC=N1 BJCHTDKEHZNQIT-UHFFFAOYSA-N 0.000 description 3
- TVEZBPGFPVKBLU-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-pyridin-3-yloxybenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CN=C1 TVEZBPGFPVKBLU-UHFFFAOYSA-N 0.000 description 3
- FAPOWYIOAWIQNZ-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[4-(trifluoromethyl)pyrimidin-2-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=NC=CC(C(F)(F)F)=N1 FAPOWYIOAWIQNZ-UHFFFAOYSA-N 0.000 description 3
- VUYGKCVXXLOQCB-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[6-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 VUYGKCVXXLOQCB-UHFFFAOYSA-N 0.000 description 3
- ILKSWXFIKPNXLL-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[6-(trifluoromethyl)pyridin-3-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)N=C1 ILKSWXFIKPNXLL-UHFFFAOYSA-N 0.000 description 3
- 229940127234 oral contraceptive Drugs 0.000 description 3
- 239000003539 oral contraceptive agent Substances 0.000 description 3
- 238000005191 phase separation Methods 0.000 description 3
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- 238000011533 pre-incubation Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 3
- 239000011877 solvent mixture Substances 0.000 description 3
- 235000000891 standard diet Nutrition 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 235000012431 wafers Nutrition 0.000 description 3
- 238000010626 work up procedure Methods 0.000 description 3
- QWQBQRYFWNIDOC-UHFFFAOYSA-N (3,5-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC(F)=CC(F)=C1 QWQBQRYFWNIDOC-UHFFFAOYSA-N 0.000 description 2
- AMSQNQJCBXQYEX-UHFFFAOYSA-N (4-methoxy-2-methylphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(C)=C1 AMSQNQJCBXQYEX-UHFFFAOYSA-N 0.000 description 2
- JEGHCYRKSUGHJH-UHFFFAOYSA-N (5-chloropyridin-2-yl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=N1 JEGHCYRKSUGHJH-UHFFFAOYSA-N 0.000 description 2
- GQWZKBTZAFEQJZ-UHFFFAOYSA-N (6-methoxypyridin-2-yl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=N1 GQWZKBTZAFEQJZ-UHFFFAOYSA-N 0.000 description 2
- DHADXDMPEUWEAS-UHFFFAOYSA-N (6-methoxypyridin-3-yl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=N1 DHADXDMPEUWEAS-UHFFFAOYSA-N 0.000 description 2
- MZUSCPDSQJSBSY-UHFFFAOYSA-N (6-methylpyridin-3-yl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=N1 MZUSCPDSQJSBSY-UHFFFAOYSA-N 0.000 description 2
- UUVDQMYRPUHXPB-UHFFFAOYSA-N 1,3-benzothiazole-2-carboxylic acid Chemical compound C1=CC=C2SC(C(=O)O)=NC2=C1 UUVDQMYRPUHXPB-UHFFFAOYSA-N 0.000 description 2
- VKPJOERCBNIOLN-UHFFFAOYSA-N 1,3-benzoxazole-2-carboxylic acid Chemical compound C1=CC=C2OC(C(=O)O)=NC2=C1 VKPJOERCBNIOLN-UHFFFAOYSA-N 0.000 description 2
- PREOONMJIVUPMI-UHFFFAOYSA-N 1,4-dioxan-2-ylmethanamine Chemical compound NCC1COCCO1 PREOONMJIVUPMI-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- YHHVGKXAIOVFOH-UHFFFAOYSA-N 1-methylbenzimidazole-2-carboxylic acid Chemical compound C1=CC=C2N(C)C(C(O)=O)=NC2=C1 YHHVGKXAIOVFOH-UHFFFAOYSA-N 0.000 description 2
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 2
- XDIAMRVROCPPBK-UHFFFAOYSA-N 2,2-dimethylpropan-1-amine Chemical compound CC(C)(C)CN XDIAMRVROCPPBK-UHFFFAOYSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- KPBXIYKZOFFPJF-UHFFFAOYSA-N 2-(cyclopropylmethoxy)ethanamine Chemical compound NCCOCC1CC1 KPBXIYKZOFFPJF-UHFFFAOYSA-N 0.000 description 2
- AFTRMCKIWUIINT-UHFFFAOYSA-N 2-(cyclopropylmethoxy)ethanamine;hydrochloride Chemical compound Cl.NCCOCC1CC1 AFTRMCKIWUIINT-UHFFFAOYSA-N 0.000 description 2
- PKYWPFQIIQKHCB-UHFFFAOYSA-N 2-(trifluoromethoxy)ethanamine;hydrochloride Chemical compound Cl.NCCOC(F)(F)F PKYWPFQIIQKHCB-UHFFFAOYSA-N 0.000 description 2
- PQTQMKOWDYNUNW-UHFFFAOYSA-N 2-(trifluoromethylsulfanyl)ethanamine Chemical compound NCCSC(F)(F)F PQTQMKOWDYNUNW-UHFFFAOYSA-N 0.000 description 2
- IDLWZJIABRFTHC-UHFFFAOYSA-N 2-[[1-(2-fluoro-4-methylsulfonylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(S(C)(=O)=O)C=C1F IDLWZJIABRFTHC-UHFFFAOYSA-N 0.000 description 2
- JFTSHWIEXZXZCK-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 JFTSHWIEXZXZCK-UHFFFAOYSA-N 0.000 description 2
- CFFSTVIZZFRKTI-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 CFFSTVIZZFRKTI-UHFFFAOYSA-N 0.000 description 2
- FOQGRBIIGXEAAQ-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 FOQGRBIIGXEAAQ-UHFFFAOYSA-N 0.000 description 2
- FPHAUIRWTHWDIL-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 FPHAUIRWTHWDIL-UHFFFAOYSA-N 0.000 description 2
- ZYZLDRCNEXMESB-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-ethyl-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 ZYZLDRCNEXMESB-UHFFFAOYSA-N 0.000 description 2
- NHBMCYFKBJKTST-UHFFFAOYSA-N 2-[[1-(4-cyano-2-fluorobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C#N)C=C1F NHBMCYFKBJKTST-UHFFFAOYSA-N 0.000 description 2
- RXKVDAUAYNREJU-UHFFFAOYSA-N 2-[[1-(4-cyclopentyloxybenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1CCCC1 RXKVDAUAYNREJU-UHFFFAOYSA-N 0.000 description 2
- PMROHKZBMLOTAV-UHFFFAOYSA-N 2-[[1-(4-cyclopropylbenzoyl)piperidin-4-yl]methyl]-4-methyl-n-(2-propan-2-yloxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1CC1 PMROHKZBMLOTAV-UHFFFAOYSA-N 0.000 description 2
- OXDQTNPWZAYLPI-UHFFFAOYSA-N 2-[[1-(4-cyclopropylbenzoyl)piperidin-4-yl]methyl]-4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1CC1 OXDQTNPWZAYLPI-UHFFFAOYSA-N 0.000 description 2
- GCCPOXDPOOCKDK-UHFFFAOYSA-N 2-[[1-(4-fluorobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(F)C=C1 GCCPOXDPOOCKDK-UHFFFAOYSA-N 0.000 description 2
- XFMYAEKQCABWRI-UHFFFAOYSA-N 2-[[1-(4-tert-butylbenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(C)(C)C)C=C1 XFMYAEKQCABWRI-UHFFFAOYSA-N 0.000 description 2
- SOHUNTJPRRRCOJ-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(C(F)(F)F)C=C1F SOHUNTJPRRRCOJ-UHFFFAOYSA-N 0.000 description 2
- HVUYCBVPKXPCIQ-UHFFFAOYSA-N 2-[[1-[4-(2,4-difluorophenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1F HVUYCBVPKXPCIQ-UHFFFAOYSA-N 0.000 description 2
- IMIKDUUZNFGYTN-UHFFFAOYSA-N 2-[[1-[4-(2-cyanopropan-2-yl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(C)(C)C#N)C=C1 IMIKDUUZNFGYTN-UHFFFAOYSA-N 0.000 description 2
- NAGGFRSJICMLMV-UHFFFAOYSA-N 2-[[1-[4-(2-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=CC=C1F NAGGFRSJICMLMV-UHFFFAOYSA-N 0.000 description 2
- HWTSTRJLABVFGZ-UHFFFAOYSA-N 2-[[1-[4-(2-hydroxypropan-2-yl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(C)(C)O)C=C1 HWTSTRJLABVFGZ-UHFFFAOYSA-N 0.000 description 2
- UVNIHEBSDIRCRA-UHFFFAOYSA-N 2-[[1-[4-(3,5-difluorophenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC(F)=CC(F)=C1 UVNIHEBSDIRCRA-UHFFFAOYSA-N 0.000 description 2
- USQDANSEYACRLK-UHFFFAOYSA-N 2-[[1-[4-(4-chlorophenoxy)benzoyl]azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(Cl)C=C1 USQDANSEYACRLK-UHFFFAOYSA-N 0.000 description 2
- CUWNCSKOWOPYHH-UHFFFAOYSA-N 2-[[1-[4-(4-chlorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(Cl)C=C1 CUWNCSKOWOPYHH-UHFFFAOYSA-N 0.000 description 2
- LPEXOYCFKAPQLM-UHFFFAOYSA-N 2-[[1-[4-(4-cyano-2-methylphenyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(C#N)C=C1C LPEXOYCFKAPQLM-UHFFFAOYSA-N 0.000 description 2
- XUSBIZYFXBNRDF-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]azetidin-3-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 XUSBIZYFXBNRDF-UHFFFAOYSA-N 0.000 description 2
- ITTAXWKAQPCSET-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 ITTAXWKAQPCSET-UHFFFAOYSA-N 0.000 description 2
- WRNDGBVJXZBBRI-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 WRNDGBVJXZBBRI-UHFFFAOYSA-N 0.000 description 2
- ZYWPWJAMBGBKRR-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]azetidin-3-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 ZYWPWJAMBGBKRR-UHFFFAOYSA-N 0.000 description 2
- IYRNJAJUBDISKW-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 IYRNJAJUBDISKW-UHFFFAOYSA-N 0.000 description 2
- TUISYWFAZCBXCE-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2-propan-2-yloxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 TUISYWFAZCBXCE-UHFFFAOYSA-N 0.000 description 2
- MBUJKFSXSHJRTQ-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 MBUJKFSXSHJRTQ-UHFFFAOYSA-N 0.000 description 2
- NRTOVHLCFNAPGD-UHFFFAOYSA-N 2-[[1-[4-(5-chloropyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(Cl)C=N1 NRTOVHLCFNAPGD-UHFFFAOYSA-N 0.000 description 2
- JFAXHNPXQPCECC-UHFFFAOYSA-N 2-[[1-[4-(5-fluoropyridin-3-yl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CN=CC(F)=C1 JFAXHNPXQPCECC-UHFFFAOYSA-N 0.000 description 2
- OWZWIOCCCSCJMG-UHFFFAOYSA-N 2-[[1-[4-chloro-3-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 OWZWIOCCCSCJMG-UHFFFAOYSA-N 0.000 description 2
- JUIKUQOUMZUFQT-UHFFFAOYSA-N 2-bromoacetamide Chemical compound NC(=O)CBr JUIKUQOUMZUFQT-UHFFFAOYSA-N 0.000 description 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 2
- BPGIOCZAQDIBPI-UHFFFAOYSA-N 2-ethoxyethanamine Chemical compound CCOCCN BPGIOCZAQDIBPI-UHFFFAOYSA-N 0.000 description 2
- UANWURKQKKYIGV-UHFFFAOYSA-N 2-methoxypropan-1-amine Chemical compound COC(C)CN UANWURKQKKYIGV-UHFFFAOYSA-N 0.000 description 2
- PPQVAHVZIBDHDB-UHFFFAOYSA-N 2-phenyl-1,3-oxazole-5-carboxylic acid Chemical compound O1C(C(=O)O)=CN=C1C1=CC=CC=C1 PPQVAHVZIBDHDB-UHFFFAOYSA-N 0.000 description 2
- LCALUFNLWHYTKX-UHFFFAOYSA-N 2-phenyl-1,3-thiazole-5-carboxylic acid Chemical compound S1C(C(=O)O)=CN=C1C1=CC=CC=C1 LCALUFNLWHYTKX-UHFFFAOYSA-N 0.000 description 2
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 2
- GBNIIFZBFSZDQA-UHFFFAOYSA-N 4-(2,4-difluorophenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(F)C=C1F GBNIIFZBFSZDQA-UHFFFAOYSA-N 0.000 description 2
- SLFZJKUFAVHARP-UHFFFAOYSA-N 4-(2-hydroxypropan-2-yl)benzoic acid Chemical compound CC(C)(O)C1=CC=C(C(O)=O)C=C1 SLFZJKUFAVHARP-UHFFFAOYSA-N 0.000 description 2
- ZWHZLANMZIXBQC-UHFFFAOYSA-N 4-(3-fluorophenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=CC(F)=C1 ZWHZLANMZIXBQC-UHFFFAOYSA-N 0.000 description 2
- JBBCZYHRHADVJB-UHFFFAOYSA-N 4-(4-cyanophenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C#N)C=C1 JBBCZYHRHADVJB-UHFFFAOYSA-N 0.000 description 2
- YLGCYYLGIDUOMC-UHFFFAOYSA-N 4-(5-chloropyridin-2-yl)oxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(Cl)C=N1 YLGCYYLGIDUOMC-UHFFFAOYSA-N 0.000 description 2
- RATSANVPHHXDCT-UHFFFAOYSA-N 4-(trifluoromethoxy)benzoic acid Chemical compound OC(=O)C1=CC=C(OC(F)(F)F)C=C1 RATSANVPHHXDCT-UHFFFAOYSA-N 0.000 description 2
- UMOGQQWVQUQTQA-UHFFFAOYSA-N 4-(trifluoromethylsulfanyl)benzoic acid Chemical compound OC(=O)C1=CC=C(SC(F)(F)F)C=C1 UMOGQQWVQUQTQA-UHFFFAOYSA-N 0.000 description 2
- BCMFTOCCLOAGBP-UHFFFAOYSA-N 4-(trifluoromethylsulfanyl)benzoyl chloride Chemical compound FC(F)(F)SC1=CC=C(C(Cl)=O)C=C1 BCMFTOCCLOAGBP-UHFFFAOYSA-N 0.000 description 2
- REDYCJOUKXVWEZ-UHFFFAOYSA-N 4-[4-(trifluoromethyl)phenoxy]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 REDYCJOUKXVWEZ-UHFFFAOYSA-N 0.000 description 2
- JXOFQKVEGRNGLD-UHFFFAOYSA-N 4-[4-(trifluoromethyl)phenyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(C(F)(F)F)C=C1 JXOFQKVEGRNGLD-UHFFFAOYSA-N 0.000 description 2
- PSSVTMMIPLAXFT-UHFFFAOYSA-N 4-[6-(trifluoromethyl)pyridin-2-yl]oxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 PSSVTMMIPLAXFT-UHFFFAOYSA-N 0.000 description 2
- TUXYZHVUPGXXQG-UHFFFAOYSA-N 4-bromobenzoic acid Chemical compound OC(=O)C1=CC=C(Br)C=C1 TUXYZHVUPGXXQG-UHFFFAOYSA-N 0.000 description 2
- PPHHAZOVVZBSCM-UHFFFAOYSA-N 4-chloro-3-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 PPHHAZOVVZBSCM-UHFFFAOYSA-N 0.000 description 2
- AXOSKPPBLDSSLL-UHFFFAOYSA-N 4-methyl-2-[[1-(4-methylbenzoyl)piperidin-4-yl]methyl]-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=CC(C)=CC=C1C(=O)N1CCC(CN2N=C3C=CC(=C(C)C3=C2)C(=O)NCCOCC(F)(F)F)CC1 AXOSKPPBLDSSLL-UHFFFAOYSA-N 0.000 description 2
- BYMIVEQELOIYAQ-UHFFFAOYSA-N 4-methyl-2-[[1-(4-morpholin-4-ylbenzoyl)piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1N1CCOCC1 BYMIVEQELOIYAQ-UHFFFAOYSA-N 0.000 description 2
- JRLBMOLVBGWKRE-UHFFFAOYSA-N 4-methyl-2-[[1-[4-(6-methylpyridin-3-yl)benzoyl]piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=NC(C)=CC=C1C1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 JRLBMOLVBGWKRE-UHFFFAOYSA-N 0.000 description 2
- JBUVXTURXBPWAS-UHFFFAOYSA-N 4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxylic acid Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Oc4ccc(cc4)C(F)(F)F)cc3)cc12)C(O)=O JBUVXTURXBPWAS-UHFFFAOYSA-N 0.000 description 2
- KPZVRDLYKKSAEF-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 KPZVRDLYKKSAEF-UHFFFAOYSA-N 0.000 description 2
- QVPWKTDGSQSDKT-UHFFFAOYSA-N 4-methyl-n-(2-methylsulfonylethyl)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCS(C)(=O)=O)C=CC2=NN1CC1CCNCC1 QVPWKTDGSQSDKT-UHFFFAOYSA-N 0.000 description 2
- WYAYBMCTSIPNCM-UHFFFAOYSA-N 4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]-2-[[1-[4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C=C1 WYAYBMCTSIPNCM-UHFFFAOYSA-N 0.000 description 2
- XVAJKPNTGSKZSQ-UHFFFAOYSA-N 4-morpholinobenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N1CCOCC1 XVAJKPNTGSKZSQ-UHFFFAOYSA-N 0.000 description 2
- NMZYANUDQSAWMB-UHFFFAOYSA-N 5-bromo-4-ethoxy-1h-indazole Chemical compound CCOC1=C(Br)C=CC2=C1C=NN2 NMZYANUDQSAWMB-UHFFFAOYSA-N 0.000 description 2
- UTDBMGRTYFPTEC-UHFFFAOYSA-N 5-bromo-6-methyl-1h-indazole Chemical compound C1=C(Br)C(C)=CC2=C1C=NN2 UTDBMGRTYFPTEC-UHFFFAOYSA-N 0.000 description 2
- UTJVSPKRDDKHND-UHFFFAOYSA-N 5-chloro-1-methylindole-2-carboxylic acid Chemical compound ClC1=CC=C2N(C)C(C(O)=O)=CC2=C1 UTJVSPKRDDKHND-UHFFFAOYSA-N 0.000 description 2
- YULGUYOVJXOPLU-UHFFFAOYSA-N 5-phenyl-1,3-oxazole-2-carboxylic acid Chemical compound O1C(C(=O)O)=NC=C1C1=CC=CC=C1 YULGUYOVJXOPLU-UHFFFAOYSA-N 0.000 description 2
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 2
- YZBILXXOZFORFE-UHFFFAOYSA-N 6-Methoxy-2-naphthoic acid Chemical compound C1=C(C(O)=O)C=CC2=CC(OC)=CC=C21 YZBILXXOZFORFE-UHFFFAOYSA-N 0.000 description 2
- JJAGLIPYTVMFTL-UHFFFAOYSA-N 7-methoxynaphthalene-2-carboxylic acid Chemical compound C1=CC(C(O)=O)=CC2=CC(OC)=CC=C21 JJAGLIPYTVMFTL-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 241001260012 Bursa Species 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 102000006771 Gonadotropins Human genes 0.000 description 2
- 108010086677 Gonadotropins Proteins 0.000 description 2
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 102000005398 Monoacylglycerol Lipase Human genes 0.000 description 2
- 108020002334 Monoacylglycerol lipase Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002675 Polyoxyl Polymers 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 2
- 102000012321 Prostanoid EP2 receptors Human genes 0.000 description 2
- 108050002848 Prostanoid EP2 receptors Proteins 0.000 description 2
- BJUIIXKBLFVQON-UHFFFAOYSA-N S(=O)(=O)=C(C(=O)NC1=CC=C(C=C1)C=1C(=NOC1C)C1=CC=CC=C1)C Chemical compound S(=O)(=O)=C(C(=O)NC1=CC=C(C=C1)C=1C(=NOC1C)C1=CC=CC=C1)C BJUIIXKBLFVQON-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OEZMIKKBMMAABO-UHFFFAOYSA-N [2-(trifluoromethyl)pyrimidin-5-yl]boronic acid Chemical compound OB(O)C1=CN=C(C(F)(F)F)N=C1 OEZMIKKBMMAABO-UHFFFAOYSA-N 0.000 description 2
- BNTIPMNMTIAWIW-UHFFFAOYSA-N [6-(trifluoromethyl)pyridin-3-yl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)N=C1 BNTIPMNMTIAWIW-UHFFFAOYSA-N 0.000 description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 2
- 150000003869 acetamides Chemical class 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001414 amino alcohols Chemical class 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 150000001499 aryl bromides Chemical class 0.000 description 2
- 150000005840 aryl radicals Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- AGSPXMVUFBBBMO-UHFFFAOYSA-N beta-aminopropionitrile Chemical compound NCCC#N AGSPXMVUFBBBMO-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical compound Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 description 2
- KTHXBEHDVMTNOH-UHFFFAOYSA-N cyclobutanol Chemical compound OC1CCC1 KTHXBEHDVMTNOH-UHFFFAOYSA-N 0.000 description 2
- 125000001352 cyclobutyloxy group Chemical group C1(CCC1)O* 0.000 description 2
- IGSKHXTUVXSOMB-UHFFFAOYSA-N cyclopropylmethanamine Chemical compound NCC1CC1 IGSKHXTUVXSOMB-UHFFFAOYSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000002622 gonadotropin Substances 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 235000013980 iron oxide Nutrition 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- HSZCZNFXUDYRKD-UHFFFAOYSA-M lithium iodide Chemical compound [Li+].[I-] HSZCZNFXUDYRKD-UHFFFAOYSA-M 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- JNPHSTCCGGZWBK-UHFFFAOYSA-N methyl 4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxylate Chemical compound COC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Oc4ccc(cc4)C(F)(F)F)cc3)cc2c1C JNPHSTCCGGZWBK-UHFFFAOYSA-N 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 230000004660 morphological change Effects 0.000 description 2
- ZXQPYJBOAQLMSZ-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-morpholin-4-ylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1N1CCOCC1 ZXQPYJBOAQLMSZ-UHFFFAOYSA-N 0.000 description 2
- ATYQRIDMMJIWRV-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-pyrazol-1-ylbenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1N1C=CC=N1 ATYQRIDMMJIWRV-UHFFFAOYSA-N 0.000 description 2
- DJVVFNUEYDBZBS-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-pyrimidin-2-yloxybenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=NC=CC=N1 DJVVFNUEYDBZBS-UHFFFAOYSA-N 0.000 description 2
- DLVNCJOKWRTGNI-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[3-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=CC(C(F)(F)F)=C1 DLVNCJOKWRTGNI-UHFFFAOYSA-N 0.000 description 2
- HVSAOXYXCUEUPC-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(oxan-4-yloxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1CCOCC1 HVSAOXYXCUEUPC-UHFFFAOYSA-N 0.000 description 2
- UGGDASPWRSNQGE-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 UGGDASPWRSNQGE-UHFFFAOYSA-N 0.000 description 2
- WMWQHQAGJYHQMZ-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C=C1 WMWQHQAGJYHQMZ-UHFFFAOYSA-N 0.000 description 2
- HFBAMOFSTONMCI-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[(2-methylpropan-2-yl)oxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC(C)(C)C)C=C1 HFBAMOFSTONMCI-UHFFFAOYSA-N 0.000 description 2
- XNIPLHIYHQTAPS-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 XNIPLHIYHQTAPS-UHFFFAOYSA-N 0.000 description 2
- IEYTWLVEPJXFTQ-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-4-methyl-2-[[1-[4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C=C1 IEYTWLVEPJXFTQ-UHFFFAOYSA-N 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 210000003101 oviduct Anatomy 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- NYGCBQKDTGBHSC-UHFFFAOYSA-N oxan-2-ylmethanamine Chemical compound NCC1CCCCO1 NYGCBQKDTGBHSC-UHFFFAOYSA-N 0.000 description 2
- NGHRATGQJXKQIQ-UHFFFAOYSA-N oxan-2-ylmethanamine;hydrochloride Chemical compound Cl.NCC1CCCCO1 NGHRATGQJXKQIQ-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- LPNBBFKOUUSUDB-UHFFFAOYSA-N p-toluic acid Chemical compound CC1=CC=C(C(O)=O)C=C1 LPNBBFKOUUSUDB-UHFFFAOYSA-N 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- SNKPOTGICZSTFF-UHFFFAOYSA-N piperidin-1-yl-[4-[4-(trifluoromethyl)phenoxy]phenyl]methanone Chemical compound FC(C1=CC=C(OC2=CC=C(C(=O)N3CCCCC3)C=C2)C=C1)(F)F SNKPOTGICZSTFF-UHFFFAOYSA-N 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000000136 postovulatory effect Effects 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002379 progesterone receptor modulator Substances 0.000 description 2
- 229940127293 prostanoid Drugs 0.000 description 2
- 150000003814 prostanoids Chemical class 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229910001923 silver oxide Inorganic materials 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- SOCAXRLFGRNEPK-IFZYUDKTSA-N (1r,3s,5r)-2-n-[1-carbamoyl-5-(cyanomethoxy)indol-3-yl]-3-n-[(3-chloro-2-fluorophenyl)methyl]-2-azabicyclo[3.1.0]hexane-2,3-dicarboxamide Chemical compound O=C([C@@H]1C[C@H]2C[C@H]2N1C(=O)NC1=CN(C2=CC=C(OCC#N)C=C21)C(=O)N)NCC1=CC=CC(Cl)=C1F SOCAXRLFGRNEPK-IFZYUDKTSA-N 0.000 description 1
- XOFNMNLYGPKKOV-UHFFFAOYSA-N (2-chloro-4-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C=C1Cl XOFNMNLYGPKKOV-UHFFFAOYSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- AYOFHWIHFCIAEK-UHFFFAOYSA-N (4-bromophenyl)-[4-[[4-methyl-1-(2,2,2-trifluoroethyl)-3H-indazol-2-yl]methyl]piperidin-1-yl]methanone Chemical compound BrC1=CC=C(C(=O)N2CCC(CC2)CN2N(C3=CC=CC(=C3C2)C)CC(F)(F)F)C=C1 AYOFHWIHFCIAEK-UHFFFAOYSA-N 0.000 description 1
- YBNDRTRLXPEWKQ-UHFFFAOYSA-N (4-chloro-2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1F YBNDRTRLXPEWKQ-UHFFFAOYSA-N 0.000 description 1
- SRXXSLUUAWHGBZ-UHFFFAOYSA-N (4-chloro-2-methylphenyl)boronic acid Chemical compound CC1=CC(Cl)=CC=C1B(O)O SRXXSLUUAWHGBZ-UHFFFAOYSA-N 0.000 description 1
- MJEHFFUUOWWTMN-UHFFFAOYSA-N (4-chlorophenyl)-[4-[[4-methyl-1-(2-propan-2-yloxyethyl)-3H-indazol-2-yl]methyl]piperidin-1-yl]methanone Chemical compound ClC1=CC=C(C(=O)N2CCC(CC2)CN2N(C3=CC=CC(=C3C2)C)CCOC(C)C)C=C1 MJEHFFUUOWWTMN-UHFFFAOYSA-N 0.000 description 1
- RGCVYEOTYJCNOS-UHFFFAOYSA-N (4-cyano-2-methylphenyl)boronic acid Chemical compound CC1=CC(C#N)=CC=C1B(O)O RGCVYEOTYJCNOS-UHFFFAOYSA-N 0.000 description 1
- IQMLIVUHMSIOQP-UHFFFAOYSA-N (4-fluoro-2-methylphenyl)boronic acid Chemical compound CC1=CC(F)=CC=C1B(O)O IQMLIVUHMSIOQP-UHFFFAOYSA-N 0.000 description 1
- MEYDGQDATZMNOL-UHFFFAOYSA-N (4-tert-butylphenyl)-[4-[[1-(2-methoxyethyl)-4-methyl-3H-indazol-2-yl]methyl]piperidin-1-yl]methanone Chemical compound C(C)(C)(C)C1=CC=C(C(=O)N2CCC(CC2)CN2N(C3=CC=CC(=C3C2)C)CCOC)C=C1 MEYDGQDATZMNOL-UHFFFAOYSA-N 0.000 description 1
- HGRWHBQLRXWSLV-DEOSSOPVSA-N (4s)-3'-(3,6-dihydro-2h-pyran-5-yl)-1'-fluoro-7'-(3-fluoropyridin-2-yl)spiro[5h-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine Chemical compound C1OC(N)=N[C@]21C1=CC(C=3COCCC=3)=NC(F)=C1OC1=CC=C(C=3C(=CC=CN=3)F)C=C12 HGRWHBQLRXWSLV-DEOSSOPVSA-N 0.000 description 1
- NJXYBTMCTZAUEE-UHFFFAOYSA-N (5-chloropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CN=CC(Cl)=C1 NJXYBTMCTZAUEE-UHFFFAOYSA-N 0.000 description 1
- KMLSWNVKDXKWGY-UHFFFAOYSA-N (5-fluoropyridin-2-yl)boronic acid Chemical compound OB(O)C1=CC=C(F)C=N1 KMLSWNVKDXKWGY-UHFFFAOYSA-N 0.000 description 1
- FVEDGBRHTGXPOK-UHFFFAOYSA-N (5-fluoropyridin-3-yl)boronic acid Chemical compound OB(O)C1=CN=CC(F)=C1 FVEDGBRHTGXPOK-UHFFFAOYSA-N 0.000 description 1
- QXWTVLPBRHGDBI-UHFFFAOYSA-N (5-methoxypyridin-2-yl)boronic acid Chemical compound COC1=CC=C(B(O)O)N=C1 QXWTVLPBRHGDBI-UHFFFAOYSA-N 0.000 description 1
- VDRIXWWGBDNWCM-UHFFFAOYSA-N (5-methylpyridin-2-yl)boronic acid Chemical compound CC1=CC=C(B(O)O)N=C1 VDRIXWWGBDNWCM-UHFFFAOYSA-N 0.000 description 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- ASUDFOJKTJLAIK-NCKGIQLSSA-N 1,1,2,2-tetradeuterio-2-(trideuteriomethoxy)ethanamine Chemical compound [2H]C([2H])([2H])OC([2H])([2H])C([2H])([2H])N ASUDFOJKTJLAIK-NCKGIQLSSA-N 0.000 description 1
- 125000005960 1,4-diazepanyl group Chemical group 0.000 description 1
- WORJRXHJTUTINR-UHFFFAOYSA-N 1,4-dioxane;hydron;chloride Chemical compound Cl.C1COCCO1 WORJRXHJTUTINR-UHFFFAOYSA-N 0.000 description 1
- 125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- MJUVRTYWUMPBTR-MRXNPFEDSA-N 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-n-[1-[(2r)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide Chemical compound FC=1C=C2N(C[C@@H](O)CO)C(C(C)(CO)C)=CC2=CC=1NC(=O)C1(C=2C=C3OC(F)(F)OC3=CC=2)CC1 MJUVRTYWUMPBTR-MRXNPFEDSA-N 0.000 description 1
- BNIWAIPNTSRALI-UHFFFAOYSA-N 1-(5-bromo-4-ethylindazol-1-yl)ethanone Chemical compound BrC=1C(=C2C=NN(C2=CC1)C(C)=O)CC BNIWAIPNTSRALI-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- OWSVSSORFLLEJR-UHFFFAOYSA-N 1-[5-bromo-4-(2,2,2-trifluoroethoxy)indazol-1-yl]ethanone Chemical compound CC(=O)N1N=CC2=C1C=CC(Br)=C2OCC(F)(F)F OWSVSSORFLLEJR-UHFFFAOYSA-N 0.000 description 1
- UYMCTXBSVGKZLM-UHFFFAOYSA-N 1-[5-bromo-4-(difluoromethoxy)indazol-1-yl]ethanone Chemical compound BrC1=CC=C2N(C(=O)C)N=CC2=C1OC(F)F UYMCTXBSVGKZLM-UHFFFAOYSA-N 0.000 description 1
- QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 description 1
- MAHAMBLNIDMREX-UHFFFAOYSA-N 1-methylindole-2-carboxylic acid Chemical compound C1=CC=C2N(C)C(C(O)=O)=CC2=C1 MAHAMBLNIDMREX-UHFFFAOYSA-N 0.000 description 1
- TZTXTIBZSSSFDI-UHFFFAOYSA-N 1-pyridin-2-ylpropan-2-one Chemical compound CC(=O)CC1=CC=CC=N1 TZTXTIBZSSSFDI-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- WQXHWCKAXLERPO-UHFFFAOYSA-N 2-(2,2,2-trifluoroethoxy)ethanamine;hydrochloride Chemical compound Cl.NCCOCC(F)(F)F WQXHWCKAXLERPO-UHFFFAOYSA-N 0.000 description 1
- HFIIWEHGDTYDGB-UHFFFAOYSA-N 2-(3-methoxyazetidin-1-yl)ethanamine Chemical compound COC1CN(CCN)C1 HFIIWEHGDTYDGB-UHFFFAOYSA-N 0.000 description 1
- YNAOYNQDIGRJEO-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-ethoxy-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(OCC)=C(C(=O)NCCOC)C=CC2=NN1CC1CNC1 YNAOYNQDIGRJEO-UHFFFAOYSA-N 0.000 description 1
- BCLBOLXXHWGYAE-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-methoxy-N-(2-methoxyethyl)indazole-5-carboxamide hydrochloride Chemical compound Cl.COCCNC(=O)c1ccc2nn(CC3CNC3)cc2c1OC BCLBOLXXHWGYAE-UHFFFAOYSA-N 0.000 description 1
- FHVRWDJQTCJEQD-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC1CNC1 FHVRWDJQTCJEQD-UHFFFAOYSA-N 0.000 description 1
- GWKPMVDQPQYSQP-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-methyl-n-(2-morpholin-4-ylethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC1CNC1 GWKPMVDQPQYSQP-UHFFFAOYSA-N 0.000 description 1
- AMSHONSWAHGYFQ-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-methyl-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC1CNC1 AMSHONSWAHGYFQ-UHFFFAOYSA-N 0.000 description 1
- AVNGSTVMAFLVJE-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-methyl-n-[2-(trifluoromethoxy)ethyl]indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCOC(F)(F)F)C=CC2=NN1CC1CNC1 AVNGSTVMAFLVJE-UHFFFAOYSA-N 0.000 description 1
- PQBSPKGITJCFIA-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-methyl-n-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCSC(F)(F)F)C=CC2=NN1CC1CNC1 PQBSPKGITJCFIA-UHFFFAOYSA-N 0.000 description 1
- BQFLSRRALCWULX-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCOC(C)(C)C)C=CC2=NN1CC1CNC1 BQFLSRRALCWULX-UHFFFAOYSA-N 0.000 description 1
- GXDULWYPHRJPAK-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-6-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C=C(C(=O)NCC(F)(F)F)C(C)=CC2=NN1CC1CNC1 GXDULWYPHRJPAK-UHFFFAOYSA-N 0.000 description 1
- ARDJRIHWOKDKQG-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-6-methyl-n-[2-(trifluoromethoxy)ethyl]indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C=C(C(=O)NCCOC(F)(F)F)C(C)=CC2=NN1CC1CNC1 ARDJRIHWOKDKQG-UHFFFAOYSA-N 0.000 description 1
- YJKPHIAXYSIEKV-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-6-methyl-n-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C=C(C(=O)NCCSC(F)(F)F)C(C)=CC2=NN1CC1CNC1 YJKPHIAXYSIEKV-UHFFFAOYSA-N 0.000 description 1
- HLYKYQNXKWLMMI-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-N-(2-cyclopropyloxyethyl)-4-methylindazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1c(ccc2nn(CC3CNC3)cc12)C(=O)NCCOC1CC1 HLYKYQNXKWLMMI-UHFFFAOYSA-N 0.000 description 1
- KLOLEISUYGKEMO-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-N-[2-(cyclopropylmethoxy)ethyl]-6-methylindazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1cc2nn(CC3CNC3)cc2cc1C(=O)NCCOCC1CC1 KLOLEISUYGKEMO-UHFFFAOYSA-N 0.000 description 1
- WDNGHDJHWUBSBR-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC1CNC1 WDNGHDJHWUBSBR-UHFFFAOYSA-N 0.000 description 1
- SIHQKGMYLICOGN-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-n-(2-methoxyethyl)-6-methylindazole-5-carboxamide;hydrochloride Chemical compound Cl.N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC1CNC1 SIHQKGMYLICOGN-UHFFFAOYSA-N 0.000 description 1
- RUGLCKZZZTXNCV-UHFFFAOYSA-N 2-(azetidin-3-ylmethyl)-n-[2-(cyclopropylmethoxy)ethyl]-4-methylindazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC1CNC1 RUGLCKZZZTXNCV-UHFFFAOYSA-N 0.000 description 1
- XHSMIYHHLZGDLU-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxy]ethylazanium;chloride Chemical compound Cl.CC(C)(C)OCCN XHSMIYHHLZGDLU-UHFFFAOYSA-N 0.000 description 1
- QDILHMPBNBYIGS-OAHLLOKOSA-N 2-[[(3R)-1-tert-butylpyrrolidin-3-yl]methyl]-4-methyl-N-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide Chemical compound C(C)(C)(C)N1C[C@@H](CC1)CN1N=C2C=CC(=C(C2=C1)C)C(NCCSC(F)(F)F)=O QDILHMPBNBYIGS-OAHLLOKOSA-N 0.000 description 1
- VSJULEGGLBMAHK-KRWDZBQOSA-N 2-[[(3s)-1-(4-chlorobenzoyl)pyrrolidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C([C@@H](C1)CN2N=C3C=CC(=C(C3=C2)C)C(=O)NCCOC)CN1C(=O)C1=CC=C(Cl)C=C1 VSJULEGGLBMAHK-KRWDZBQOSA-N 0.000 description 1
- ONQNWYKGCSEFLF-NRFANRHFSA-N 2-[[(3s)-1-[4-(4-fluorophenyl)benzoyl]pyrrolidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C([C@@H](C1)CN2N=C3C=CC(=C(C3=C2)C)C(=O)NCCOC)CN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=C1 ONQNWYKGCSEFLF-NRFANRHFSA-N 0.000 description 1
- ANZQXTMKXMCOMQ-UHFFFAOYSA-N 2-[[1-(1,3-benzothiazole-2-carbonyl)piperidin-4-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound S1C(=NC2=C1C=CC=C2)C(=O)N2CCC(CC2)CN2N=C1C=CC(=C(C1=C2)C)C(=O)NCC(F)(F)F ANZQXTMKXMCOMQ-UHFFFAOYSA-N 0.000 description 1
- RSKXEMMNXTZFRA-UHFFFAOYSA-N 2-[[1-(1,3-benzothiazole-2-carbonyl)piperidin-4-yl]methyl]-N-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound S1C(=NC2=C1C=CC=C2)C(=O)N2CCC(CC2)CN2N=C1C=CC(=C(C1=C2)C)C(=O)NCCOC RSKXEMMNXTZFRA-UHFFFAOYSA-N 0.000 description 1
- GTKBWGCYLWTLCL-UHFFFAOYSA-N 2-[[1-(1,3-benzoxazole-2-carbonyl)piperidin-4-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound O1C(=NC2=C1C=CC=C2)C(=O)N2CCC(CC2)CN2N=C1C=CC(=C(C1=C2)C)C(=O)NCC(F)(F)F GTKBWGCYLWTLCL-UHFFFAOYSA-N 0.000 description 1
- VNADERSNNKAWEJ-UHFFFAOYSA-N 2-[[1-(1,3-benzoxazole-2-carbonyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=CC=C2OC(C(=O)N3CCC(CC3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCCOC)=NC2=C1 VNADERSNNKAWEJ-UHFFFAOYSA-N 0.000 description 1
- DDHQQNGOLVGGCT-UHFFFAOYSA-N 2-[[1-(1H-indole-2-carbonyl)piperidin-4-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound N1C(=CC2=CC=CC=C12)C(=O)N1CCC(CC1)CN1N=C2C=CC(=C(C2=C1)C)C(=O)NCC(F)(F)F DDHQQNGOLVGGCT-UHFFFAOYSA-N 0.000 description 1
- GLCNMIMCUGOPOH-UHFFFAOYSA-N 2-[[1-(3,5-difluorobenzoyl)azetidin-3-yl]methyl]-n-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC(C1)CN1C(=O)C1=CC(F)=CC(F)=C1 GLCNMIMCUGOPOH-UHFFFAOYSA-N 0.000 description 1
- LWSBEXWVVGHJGR-UHFFFAOYSA-N 2-[[1-(4-bromobenzoyl)azetidin-3-yl]methyl]-4-methoxy-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Br)C=C1 LWSBEXWVVGHJGR-UHFFFAOYSA-N 0.000 description 1
- VTQAQVSSAYNWNF-UHFFFAOYSA-N 2-[[1-(4-bromobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-(2-methylsulfonylethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCS(C)(=O)=O)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Br)C=C1 VTQAQVSSAYNWNF-UHFFFAOYSA-N 0.000 description 1
- KGJORUJGWRZEBK-UHFFFAOYSA-N 2-[[1-(4-chloro-2-fluorobenzoyl)azetidin-3-yl]methyl]-N-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound ClC1=CC(=C(C(=O)N2CC(C2)CN2N=C3C=C(C(=CC3=C2)C(=O)NCCOC)C)C=C1)F KGJORUJGWRZEBK-UHFFFAOYSA-N 0.000 description 1
- SGHGNCNIJFUOJC-UHFFFAOYSA-N 2-[[1-(4-chloro-2-fluorobenzoyl)piperidin-4-yl]methyl]-4-methoxy-N-(2-methoxyethyl)indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Cl)cc3F)cc2c1OC SGHGNCNIJFUOJC-UHFFFAOYSA-N 0.000 description 1
- LZYBDJWPUSUBHB-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-ethoxy-N-(2-methoxyethyl)indazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CC(C2)CN2N=C3C=CC(=C(C3=C2)OCC)C(=O)NCCOC)C=C1 LZYBDJWPUSUBHB-UHFFFAOYSA-N 0.000 description 1
- LRBYMWYMCLPWCL-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methoxy-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 LRBYMWYMCLPWCL-UHFFFAOYSA-N 0.000 description 1
- BFARLBOHINBSTN-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methoxy-n-(2-morpholin-4-ylethyl)indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 BFARLBOHINBSTN-UHFFFAOYSA-N 0.000 description 1
- KZFIUWHYOXJAPP-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methoxyindazole-5-carboxylic acid Chemical compound C1=C2C(OC)=C(C(O)=O)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 KZFIUWHYOXJAPP-UHFFFAOYSA-N 0.000 description 1
- DSIPBJGXKIYDAW-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methyl-N-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CN(C3)C(=O)c3ccc(Cl)cc3)cc12)C(=O)NCCSC(F)(F)F DSIPBJGXKIYDAW-UHFFFAOYSA-N 0.000 description 1
- NHQRHFZBGCJACY-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methyl-n-(2-morpholin-4-ylethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 NHQRHFZBGCJACY-UHFFFAOYSA-N 0.000 description 1
- ORNLMIGUIQUIBU-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-6-methyl-N-[2-(trifluoromethoxy)ethyl]indazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CC(C2)CN2N=C3C=C(C(=CC3=C2)C(=O)NCCOC(F)(F)F)C)C=C1 ORNLMIGUIQUIBU-UHFFFAOYSA-N 0.000 description 1
- ACRIUBZHGIRSFS-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-6-methyl-N-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide Chemical compound Cc1cc2nn(CC3CN(C3)C(=O)c3ccc(Cl)cc3)cc2cc1C(=O)NCCSC(F)(F)F ACRIUBZHGIRSFS-UHFFFAOYSA-N 0.000 description 1
- PENWEUZRCYMMLR-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-6-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C=C(C(=O)NCC(F)(F)F)C(C)=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 PENWEUZRCYMMLR-UHFFFAOYSA-N 0.000 description 1
- GXMCIUPSDKLGML-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-6-methyl-n-(2-morpholin-4-ylethyl)indazole-5-carboxamide Chemical compound C1=C2C=C(C(=O)NCCN3CCOCC3)C(C)=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 GXMCIUPSDKLGML-UHFFFAOYSA-N 0.000 description 1
- ZLQCMYHYPBOPJA-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-N-[2-(cyclopropylmethoxy)ethyl]-6-methylindazole-5-carboxamide Chemical compound CC1=CC2=NN(CC3CN(C3)C(=O)C3=CC=C(Cl)C=C3)C=C2C=C1C(=O)NCCOCC1CC1 ZLQCMYHYPBOPJA-UHFFFAOYSA-N 0.000 description 1
- IXKVTGJIGQHQJU-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-n-(2-ethoxyethyl)-4-methoxyindazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOCC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 IXKVTGJIGQHQJU-UHFFFAOYSA-N 0.000 description 1
- BGNRYSWUBNZIDT-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-n-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 BGNRYSWUBNZIDT-UHFFFAOYSA-N 0.000 description 1
- INAAAGJODLCAEO-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-(difluoromethoxy)-N-(2-methoxyethyl)indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Cl)cc3)cc2c1OC(F)F INAAAGJODLCAEO-UHFFFAOYSA-N 0.000 description 1
- JQPYEQWNCZGIDS-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-ethoxy-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(OCC)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 JQPYEQWNCZGIDS-UHFFFAOYSA-N 0.000 description 1
- ABOOLNHZGLFVSA-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-ethyl-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(CC)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 ABOOLNHZGLFVSA-UHFFFAOYSA-N 0.000 description 1
- JFYWBVZMUJLVSQ-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methoxy-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CCC(CC2)CN2N=C3C=CC(=C(C3=C2)OC)C(=O)NCC(F)(F)F)C=C1 JFYWBVZMUJLVSQ-UHFFFAOYSA-N 0.000 description 1
- KFNLZYOSAJTUPD-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methoxy-N-(2-morpholin-4-ylethyl)indazole-5-carboxamide Chemical compound COc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Cl)cc3)cc12)C(=O)NCCN1CCOCC1 KFNLZYOSAJTUPD-UHFFFAOYSA-N 0.000 description 1
- ZSZWVFATDLLBLG-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methoxy-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 ZSZWVFATDLLBLG-UHFFFAOYSA-N 0.000 description 1
- OHCNXSGMPCESAH-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methoxyindazole-5-carboxylic acid Chemical compound C1=C2C(OC)=C(C(O)=O)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 OHCNXSGMPCESAH-UHFFFAOYSA-N 0.000 description 1
- CLVMOIPCAWJKHQ-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-(2-methylpropyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 CLVMOIPCAWJKHQ-UHFFFAOYSA-N 0.000 description 1
- LPDUPNUFYCLVMD-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methyl-n-(2-morpholin-4-ylethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 LPDUPNUFYCLVMD-UHFFFAOYSA-N 0.000 description 1
- UYJHFUUVFGGASK-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methylindazole-5-carboxylic acid Chemical compound C1=C2C(C)=C(C(O)=O)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 UYJHFUUVFGGASK-UHFFFAOYSA-N 0.000 description 1
- IXFMNEUNZSQCBC-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-6-methyl-n-(2-morpholin-4-ylethyl)indazole-5-carboxamide Chemical compound C1=C2C=C(C(=O)NCCN3CCOCC3)C(C)=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 IXFMNEUNZSQCBC-UHFFFAOYSA-N 0.000 description 1
- WIAKTIPQTLHAKI-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-N-(2-methoxyethyl)-4-(2,2,2-trifluoroethoxy)indazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CCC(CC2)CN2N=C3C=CC(=C(C3=C2)OCC(F)(F)F)C(=O)NCCOC)C=C1 WIAKTIPQTLHAKI-UHFFFAOYSA-N 0.000 description 1
- SLKMWOPYEREAMF-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-N-(3-hydroxy-3-methylbutyl)-4-methylindazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Cl)cc3)cc12)C(=O)NCCC(C)(C)O SLKMWOPYEREAMF-UHFFFAOYSA-N 0.000 description 1
- XBZHJYFLIQANIP-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-N-(cyanomethyl)-4-methylindazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CCC(CC2)CN2N=C3C=CC(=C(C3=C2)C)C(=O)NCC#N)C=C1 XBZHJYFLIQANIP-UHFFFAOYSA-N 0.000 description 1
- JGYGKCJFVOHBTG-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-N-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-4-methylindazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CCC(CC2)CN2N=C3C=CC(=C(C3=C2)C)C(=O)NCCN2CC(CC2)(F)F)C=C1 JGYGKCJFVOHBTG-UHFFFAOYSA-N 0.000 description 1
- FOMBTJASXGUPGO-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-N-[2-(3-methoxyazetidin-1-yl)ethyl]-4-methylindazole-5-carboxamide Chemical compound ClC1=CC=C(C(=O)N2CCC(CC2)CN2N=C3C=CC(=C(C3=C2)C)C(=O)NCCN2CC(C2)OC)C=C1 FOMBTJASXGUPGO-UHFFFAOYSA-N 0.000 description 1
- LPJKKULRDKRPBM-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-N-[2-(cyclopropylmethoxy)ethyl]-4-(2,2,2-trifluoroethoxy)indazole-5-carboxamide Chemical compound FC(F)(F)COc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Cl)cc3)cc12)C(=O)NCCOCC1CC1 LPJKKULRDKRPBM-UHFFFAOYSA-N 0.000 description 1
- XIJBHKYOBNOPTC-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(2,2-dimethylpropyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(C)(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 XIJBHKYOBNOPTC-UHFFFAOYSA-N 0.000 description 1
- GOXXVOOPHVAVLV-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(2-cyanoethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCC#N)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 GOXXVOOPHVAVLV-UHFFFAOYSA-N 0.000 description 1
- DWTYFGZVMSKNPX-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(2-ethoxyethyl)-4-methoxyindazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOCC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 DWTYFGZVMSKNPX-UHFFFAOYSA-N 0.000 description 1
- QOWRJSCGUQSQLG-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(2-hydroxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCO)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 QOWRJSCGUQSQLG-UHFFFAOYSA-N 0.000 description 1
- AQEFUOYTPZGMJC-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 AQEFUOYTPZGMJC-UHFFFAOYSA-N 0.000 description 1
- AJBWOZHFROUMFM-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(3-hydroxypropyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCCO)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 AJBWOZHFROUMFM-UHFFFAOYSA-N 0.000 description 1
- VQGSDCOZGXFKHF-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(cyclobutylmethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC3CCC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 VQGSDCOZGXFKHF-UHFFFAOYSA-N 0.000 description 1
- BLRPEZHRWABLEH-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-(cyclopropylmethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 BLRPEZHRWABLEH-UHFFFAOYSA-N 0.000 description 1
- SBZDLWGGEMEFNZ-UHFFFAOYSA-N 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-n-[2-(cyclopropylmethoxy)ethyl]-4-(difluoromethoxy)indazole-5-carboxamide Chemical compound C1=C2C(OC(F)F)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 SBZDLWGGEMEFNZ-UHFFFAOYSA-N 0.000 description 1
- GJIRHWSVKLQBAH-UHFFFAOYSA-N 2-[[1-(4-cyclopropylbenzoyl)azetidin-3-yl]methyl]-n-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC(C1)CN1C(=O)C(C=C1)=CC=C1C1CC1 GJIRHWSVKLQBAH-UHFFFAOYSA-N 0.000 description 1
- FNKPZARSDVDKNR-UHFFFAOYSA-N 2-[[1-(4-cyclopropylbenzoyl)piperidin-4-yl]methyl]-4-(difluoromethoxy)-N-(2-methoxyethyl)indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)C3CC3)cc2c1OC(F)F FNKPZARSDVDKNR-UHFFFAOYSA-N 0.000 description 1
- XIJPVHBYMIXKGN-UHFFFAOYSA-N 2-[[1-(5-chloro-1-methylindole-2-carbonyl)azetidin-3-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound ClC1=CC=C2N(C)C(C(=O)N3CC(C3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCCOC)=CC2=C1 XIJPVHBYMIXKGN-UHFFFAOYSA-N 0.000 description 1
- NUTAQDYGEZKKNT-UHFFFAOYSA-N 2-[[1-(5-chloro-1-methylindole-2-carbonyl)piperidin-4-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound ClC=1C=C2C=C(N(C2=CC1)C)C(=O)N1CCC(CC1)CN1N=C2C=CC(=C(C2=C1)C)C(=O)NCC(F)(F)F NUTAQDYGEZKKNT-UHFFFAOYSA-N 0.000 description 1
- IYUDNXOMPMKECW-UHFFFAOYSA-N 2-[[1-(5-fluoro-1-methylindole-2-carbonyl)azetidin-3-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CN(C3)C(=O)c3cc4cc(F)ccc4n3C)cc12)C(=O)NCC(F)(F)F IYUDNXOMPMKECW-UHFFFAOYSA-N 0.000 description 1
- RSRGNWVEJIBMPY-UHFFFAOYSA-N 2-[[1-(5-fluoro-1-methylindole-2-carbonyl)piperidin-4-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3cc4cc(F)ccc4n3C)cc12)C(=O)NCC(F)(F)F RSRGNWVEJIBMPY-UHFFFAOYSA-N 0.000 description 1
- YGGOXCCAGJPFCO-UHFFFAOYSA-N 2-[[1-(6-methoxy-1-methylindole-2-carbonyl)azetidin-3-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound COC1=CC=C2C=C(N(C2=C1)C)C(=O)N1CC(C1)CN1N=C2C=CC(=C(C2=C1)C)C(=O)NCC(F)(F)F YGGOXCCAGJPFCO-UHFFFAOYSA-N 0.000 description 1
- SDVITMFDTUNNJD-UHFFFAOYSA-N 2-[[1-(6-methoxy-1-methylindole-2-carbonyl)piperidin-4-yl]methyl]-4-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound COc1ccc2cc(C(=O)N3CCC(Cn4cc5c(C)c(ccc5n4)C(=O)NCC(F)(F)F)CC3)n(C)c2c1 SDVITMFDTUNNJD-UHFFFAOYSA-N 0.000 description 1
- ACDWMIZBFPJQBR-UHFFFAOYSA-N 2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]-4-(2,2,2-trifluoroethoxy)indazole-5-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC(Cn2cc3c(OCC(F)(F)F)c(ccc3n2)C(O)=O)CC1 ACDWMIZBFPJQBR-UHFFFAOYSA-N 0.000 description 1
- FCSOFDZNTNJBCV-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-4-methoxy-N-(2-methoxyethyl)indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CN(C3)C(=O)c3ccc(cc3F)C(F)(F)F)cc2c1OC FCSOFDZNTNJBCV-UHFFFAOYSA-N 0.000 description 1
- FDQFVXLNMCSMQK-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-4-methyl-n-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCSC(F)(F)F)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(C(F)(F)F)C=C1F FDQFVXLNMCSMQK-UHFFFAOYSA-N 0.000 description 1
- RKHCJSDABIJSTB-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-N-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound FC1=C(C(=O)N2CC(C2)CN2N=C3C=C(C(=CC3=C2)C(=O)NCCOC)C)C=CC(=C1)C(F)(F)F RKHCJSDABIJSTB-UHFFFAOYSA-N 0.000 description 1
- HYVLVHFQNVRZIH-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]-4-methoxy-N-(2-methoxyethyl)indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3F)C(F)(F)F)cc2c1OC HYVLVHFQNVRZIH-UHFFFAOYSA-N 0.000 description 1
- AMJYJIMQVJJWHH-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2-morpholin-4-ylethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C=C1F AMJYJIMQVJJWHH-UHFFFAOYSA-N 0.000 description 1
- MABIFSPCNCTPSV-UHFFFAOYSA-N 2-[[1-[2-fluoro-4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]-N-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound COCCNC(=O)c1cc2cn(CC3CCN(CC3)C(=O)c3ccc(cc3F)C(F)(F)F)nc2cc1C MABIFSPCNCTPSV-UHFFFAOYSA-N 0.000 description 1
- OWWNXMQVEGZSSX-UHFFFAOYSA-N 2-[[1-[3-fluoro-4-(trifluoromethoxy)benzoyl]piperidin-4-yl]methyl]-4-methoxy-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC(F)(F)F)C(F)=C1 OWWNXMQVEGZSSX-UHFFFAOYSA-N 0.000 description 1
- MVDHBJGIPYPRPQ-UHFFFAOYSA-N 2-[[1-[3-fluoro-4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-n-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC(C1)CN1C(=O)C1=CC=C(C(F)(F)F)C(F)=C1 MVDHBJGIPYPRPQ-UHFFFAOYSA-N 0.000 description 1
- BZYYLUDQKZCQQK-UHFFFAOYSA-N 2-[[1-[3-fluoro-4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C(F)=C1 BZYYLUDQKZCQQK-UHFFFAOYSA-N 0.000 description 1
- TVAWFTRJLAFTSO-UHFFFAOYSA-N 2-[[1-[4-(3,5-difluorophenyl)-3-methylbenzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1C)=CC=C1C1=CC(F)=CC(F)=C1 TVAWFTRJLAFTSO-UHFFFAOYSA-N 0.000 description 1
- ILPKCMFEEBKCNO-UHFFFAOYSA-N 2-[[1-[4-(4-carbamoylphenoxy)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(N)=O)C=C1 ILPKCMFEEBKCNO-UHFFFAOYSA-N 0.000 description 1
- NWGQZTYEDOUTHS-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]-N-(2-methoxyethyl)-4-(2,2,2-trifluoroethoxy)indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Oc4ccc(F)cc4)cc3)cc2c1OCC(F)(F)F NWGQZTYEDOUTHS-UHFFFAOYSA-N 0.000 description 1
- DMKDYEPADDLIMU-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]azetidin-3-yl]methyl]-6-methyl-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound Cc1cc2nn(CC3CN(C3)C(=O)c3ccc(cc3)-c3ccc(F)cc3)cc2cc1C(=O)NCC(F)(F)F DMKDYEPADDLIMU-UHFFFAOYSA-N 0.000 description 1
- SVALOBORAQQNKT-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]azetidin-3-yl]methyl]-N-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound COCCNC(=O)c1cc2cn(CC3CN(C3)C(=O)c3ccc(cc3)-c3ccc(F)cc3)nc2cc1C SVALOBORAQQNKT-UHFFFAOYSA-N 0.000 description 1
- IPSJEBLYCOWYIZ-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-N-(2-methylsulfonylethyl)indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)-c3ccc(F)cc3)cc12)C(=O)NCCS(C)(=O)=O IPSJEBLYCOWYIZ-UHFFFAOYSA-N 0.000 description 1
- LOXPYQOUPJBBIJ-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-4-methyl-N-[2-[(2-methylpropan-2-yl)oxy]ethyl]indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)-c3ccc(F)cc3)cc12)C(=O)NCCOC(C)(C)C LOXPYQOUPJBBIJ-UHFFFAOYSA-N 0.000 description 1
- JAIFNHOLTDIIGY-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-N-(2-hydroxyethyl)-4-methylindazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)-c3ccc(F)cc3)cc12)C(=O)NCCO JAIFNHOLTDIIGY-UHFFFAOYSA-N 0.000 description 1
- QSWHAYUCFZASPG-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-N-(2-methoxyethyl)-4-(2,2,2-trifluoroethoxy)indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)-c3ccc(F)cc3)cc2c1OCC(F)(F)F QSWHAYUCFZASPG-UHFFFAOYSA-N 0.000 description 1
- BUBIOAKHUNDAQZ-UHFFFAOYSA-N 2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-4-yl]methyl]-N-(3-hydroxypropyl)-4-methylindazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(cc3)-c3ccc(F)cc3)cc12)C(=O)NCCCO BUBIOAKHUNDAQZ-UHFFFAOYSA-N 0.000 description 1
- YLFQYBOAQAWUIL-UHFFFAOYSA-N 2-[[1-[4-(5-chloropyridin-3-yl)benzoyl]piperidin-4-yl]methyl]-n-(2-methoxyethyl)-4-methylindazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CN=CC(Cl)=C1 YLFQYBOAQAWUIL-UHFFFAOYSA-N 0.000 description 1
- CAQNCAAXPJMNIT-UHFFFAOYSA-N 2-[[1-[4-(5-fluoropyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=C(F)C=N1 CAQNCAAXPJMNIT-UHFFFAOYSA-N 0.000 description 1
- PUQACUPGSBAFRQ-UHFFFAOYSA-N 2-[[1-[4-(6-methoxypyridin-3-yl)benzoyl]piperidin-4-yl]methyl]-4-methyl-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=NC(OC)=CC=C1C1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 PUQACUPGSBAFRQ-UHFFFAOYSA-N 0.000 description 1
- DSMCOUYNFUTLQU-UHFFFAOYSA-N 2-[[1-[4-chloro-3-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-4-methoxy-N-(2-methoxyethyl)indazole-5-carboxamide Chemical compound ClC1=C(C=C(C(=O)N2CC(C2)CN2N=C3C=CC(=C(C3=C2)OC)C(=O)NCCOC)C=C1)C(F)(F)F DSMCOUYNFUTLQU-UHFFFAOYSA-N 0.000 description 1
- YIULDGQDRCIQRG-UHFFFAOYSA-N 2-[[1-[4-chloro-3-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]-N-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound COCCNC(=O)c1cc2cn(CC3CN(C3)C(=O)c3ccc(Cl)c(c3)C(F)(F)F)nc2cc1C YIULDGQDRCIQRG-UHFFFAOYSA-N 0.000 description 1
- QQOSODJEYFXQBG-UHFFFAOYSA-N 2-[[1-[4-chloro-3-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]-4-methoxy-n-(2-methoxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C(C(F)(F)F)=C1 QQOSODJEYFXQBG-UHFFFAOYSA-N 0.000 description 1
- OGDQZWBEVSUQFL-UHFFFAOYSA-N 2-[[1-[4-chloro-3-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]-N-(2-methoxyethyl)-6-methylindazole-5-carboxamide Chemical compound COCCNC(=O)c1cc2cn(CC3CCN(CC3)C(=O)c3ccc(Cl)c(c3)C(F)(F)F)nc2cc1C OGDQZWBEVSUQFL-UHFFFAOYSA-N 0.000 description 1
- XFKYKTBPRBZDFG-UHFFFAOYSA-N 2-aminoacetonitrile;hydrochloride Chemical compound Cl.NCC#N XFKYKTBPRBZDFG-UHFFFAOYSA-N 0.000 description 1
- AUHYZQCEIVEMFH-UHFFFAOYSA-N 2-bromopropanamide Chemical compound CC(Br)C(N)=O AUHYZQCEIVEMFH-UHFFFAOYSA-N 0.000 description 1
- XOUFUYNNQPAWFG-UHFFFAOYSA-N 2-cyclobutyloxyethanamine Chemical compound NCCOC1CCC1 XOUFUYNNQPAWFG-UHFFFAOYSA-N 0.000 description 1
- UEIUXMIRJHTFMM-UHFFFAOYSA-N 2-cyclobutyloxypropan-1-amine Chemical compound NCC(C)OC1CCC1 UEIUXMIRJHTFMM-UHFFFAOYSA-N 0.000 description 1
- UJDWSAIJHBTJBA-UHFFFAOYSA-N 2-cyclobutyloxypropanamide Chemical compound NC(=O)C(C)OC1CCC1 UJDWSAIJHBTJBA-UHFFFAOYSA-N 0.000 description 1
- HPPGJEHFJAJRGP-UHFFFAOYSA-N 2-cyclopropyloxyethylazanium;2,2,2-trifluoroacetate Chemical compound [NH3+]CCOC1CC1.[O-]C(=O)C(F)(F)F HPPGJEHFJAJRGP-UHFFFAOYSA-N 0.000 description 1
- FRIJTPHMEJFKSW-UHFFFAOYSA-N 2-fluoro-4-(2-fluoro-4-methoxyphenyl)benzoic acid Chemical compound FC1=CC(OC)=CC=C1C1=CC=C(C(O)=O)C(F)=C1 FRIJTPHMEJFKSW-UHFFFAOYSA-N 0.000 description 1
- UPWMPIKNUXTWFP-UHFFFAOYSA-N 2-fluoro-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C(F)=C1 UPWMPIKNUXTWFP-UHFFFAOYSA-N 0.000 description 1
- ALFWHEYHCZRVLO-UHFFFAOYSA-N 2-fluoro-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(F)=C1 ALFWHEYHCZRVLO-UHFFFAOYSA-N 0.000 description 1
- WAIWHRUQKRUWAH-UHFFFAOYSA-N 2-fluoro-4-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=C(C(O)=O)C(F)=C1 WAIWHRUQKRUWAH-UHFFFAOYSA-N 0.000 description 1
- LFYMPARUPZDGHJ-UHFFFAOYSA-N 2-fluoro-4-propan-2-yloxybenzoic acid Chemical compound CC(C)OC1=CC=C(C(O)=O)C(F)=C1 LFYMPARUPZDGHJ-UHFFFAOYSA-N 0.000 description 1
- HFHFGHLXUCOHLN-UHFFFAOYSA-N 2-fluorophenol Chemical compound OC1=CC=CC=C1F HFHFGHLXUCOHLN-UHFFFAOYSA-N 0.000 description 1
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 1
- KUXMBHWMSQIASW-UHFFFAOYSA-N 2-methyl-3-(2,2,2-trifluoroethoxy)aniline Chemical compound CC1=C(N)C=CC=C1OCC(F)(F)F KUXMBHWMSQIASW-UHFFFAOYSA-N 0.000 description 1
- BGGIUGXMWNKMCP-UHFFFAOYSA-N 2-methylpropan-2-olate;zirconium(4+) Chemical compound CC(C)(C)O[Zr](OC(C)(C)C)(OC(C)(C)C)OC(C)(C)C BGGIUGXMWNKMCP-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 1
- PLAZTCDQAHEYBI-UHFFFAOYSA-N 2-nitrotoluene Chemical compound CC1=CC=CC=C1[N+]([O-])=O PLAZTCDQAHEYBI-UHFFFAOYSA-N 0.000 description 1
- OYZWEOORLJBPMA-UHFFFAOYSA-N 3,5-difluorobenzoyl chloride Chemical compound FC1=CC(F)=CC(C(Cl)=O)=C1 OYZWEOORLJBPMA-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- REBSFMJFKKVQBS-UHFFFAOYSA-N 3-(difluoromethoxy)-2-methylaniline Chemical compound CC1=C(N)C=CC=C1OC(F)F REBSFMJFKKVQBS-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- AKFDIYXSRGLRAB-UHFFFAOYSA-N 3-(pentafluoro-$l^{6}-sulfanyl)benzoic acid Chemical compound OC(=O)C1=CC=CC(S(F)(F)(F)(F)F)=C1 AKFDIYXSRGLRAB-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- FMEFWHZBWLPUFV-UHFFFAOYSA-N 3-ethyl-2-methylaniline;hydrochloride Chemical compound Cl.CCC1=CC=CC(N)=C1C FMEFWHZBWLPUFV-UHFFFAOYSA-N 0.000 description 1
- PIBFTHWKVKHHMA-UHFFFAOYSA-N 3-fluoro-4-(trifluoromethoxy)benzoic acid Chemical compound OC(=O)C1=CC=C(OC(F)(F)F)C(F)=C1 PIBFTHWKVKHHMA-UHFFFAOYSA-N 0.000 description 1
- DPDAEMNQJYDHRQ-UHFFFAOYSA-N 3-fluoro-4-(trifluoromethyl)benzoyl chloride Chemical compound FC1=CC(C(Cl)=O)=CC=C1C(F)(F)F DPDAEMNQJYDHRQ-UHFFFAOYSA-N 0.000 description 1
- SFWWGMKXCYLZEG-UHFFFAOYSA-N 3-methylmorpholine Chemical compound CC1COCCN1 SFWWGMKXCYLZEG-UHFFFAOYSA-N 0.000 description 1
- OMPOBDCBGHUPBD-UHFFFAOYSA-N 3-phenyl-1,2,4-oxadiazole-5-carboxylic acid Chemical compound O1C(C(=O)O)=NC(C=2C=CC=CC=2)=N1 OMPOBDCBGHUPBD-UHFFFAOYSA-N 0.000 description 1
- LZPWAYBEOJRFAX-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane Chemical compound CC1(C)O[B]OC1(C)C LZPWAYBEOJRFAX-UHFFFAOYSA-N 0.000 description 1
- MAVFXLXXHAMJTB-UHFFFAOYSA-N 4-(2-cyanopropan-2-yl)benzoic acid Chemical compound N#CC(C)(C)C1=CC=C(C(O)=O)C=C1 MAVFXLXXHAMJTB-UHFFFAOYSA-N 0.000 description 1
- DRSHBFVQGWCVMK-UHFFFAOYSA-N 4-(3,4-difluorophenoxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(F)C(F)=C1 DRSHBFVQGWCVMK-UHFFFAOYSA-N 0.000 description 1
- DTYQQHFUTOPXLE-UHFFFAOYSA-N 4-(3,4-dimethylphenyl)-2-fluorobenzoic acid Chemical compound C1=C(C)C(C)=CC=C1C1=CC=C(C(O)=O)C(F)=C1 DTYQQHFUTOPXLE-UHFFFAOYSA-N 0.000 description 1
- FDPKGXQCDURRBM-UHFFFAOYSA-N 4-(4-methoxyphenyl)benzoic acid Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C(O)=O)C=C1 FDPKGXQCDURRBM-UHFFFAOYSA-N 0.000 description 1
- IVUDWMJNAPABOO-UHFFFAOYSA-N 4-(5-cyanopyridin-2-yl)oxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=C(C#N)C=N1 IVUDWMJNAPABOO-UHFFFAOYSA-N 0.000 description 1
- YTGVHTSHZABIRF-UHFFFAOYSA-N 4-(difluoromethoxy)-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]indazole-5-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC(Cn2cc3c(OC(F)F)c(ccc3n2)C(O)=O)CC1 YTGVHTSHZABIRF-UHFFFAOYSA-N 0.000 description 1
- KUPBYNWMWXPSBR-UHFFFAOYSA-N 4-(difluoromethoxy)-N-(2-methoxyethyl)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide hydrochloride Chemical compound Cl.COCCNC(=O)c1ccc2nn(CC3CCNCC3)cc2c1OC(F)F KUPBYNWMWXPSBR-UHFFFAOYSA-N 0.000 description 1
- BSNNYLYELGBSBA-UHFFFAOYSA-N 4-(difluoromethoxy)benzoic acid Chemical compound OC(=O)C1=CC=C(OC(F)F)C=C1 BSNNYLYELGBSBA-UHFFFAOYSA-N 0.000 description 1
- MPNYLYRGNCZFFH-UHFFFAOYSA-N 4-(oxan-4-yloxy)benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1CCOCC1 MPNYLYRGNCZFFH-UHFFFAOYSA-N 0.000 description 1
- OXZYBOLWRXENKT-UHFFFAOYSA-N 4-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=C(C(Cl)=O)C=C1 OXZYBOLWRXENKT-UHFFFAOYSA-N 0.000 description 1
- AEGOKCWNWMOZBS-UHFFFAOYSA-N 4-(trifluoromethylsulfinyl)benzoyl chloride Chemical compound FC(S(=O)C1=CC=C(C(=O)Cl)C=C1)(F)F AEGOKCWNWMOZBS-UHFFFAOYSA-N 0.000 description 1
- WHTBQELRENWGTE-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxy]benzoic acid Chemical compound CC(C)(C)OC1=CC=C(C(O)=O)C=C1 WHTBQELRENWGTE-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- FSLUYPHZCSKJJZ-UHFFFAOYSA-N 4-[5-(trifluoromethyl)pyridin-2-yl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1=CC=C(C(F)(F)F)C=N1 FSLUYPHZCSKJJZ-UHFFFAOYSA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- PUSZHIWAFZLOMD-UHFFFAOYSA-N 4-amino-2-methylbutan-2-ol Chemical compound CC(C)(O)CCN PUSZHIWAFZLOMD-UHFFFAOYSA-N 0.000 description 1
- PSIAIIWLJMABGE-UHFFFAOYSA-N 4-bromo-3-ethyl-2-methylaniline Chemical compound CCC1=C(C)C(N)=CC=C1Br PSIAIIWLJMABGE-UHFFFAOYSA-N 0.000 description 1
- KWVXDZLVCISXIB-UHFFFAOYSA-N 4-bromo-3-methylbenzoic acid Chemical compound CC1=CC(C(O)=O)=CC=C1Br KWVXDZLVCISXIB-UHFFFAOYSA-N 0.000 description 1
- DENKGPBHLYFNGK-UHFFFAOYSA-N 4-bromobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Br)C=C1 DENKGPBHLYFNGK-UHFFFAOYSA-N 0.000 description 1
- PWHFJLCMUCFYRQ-UHFFFAOYSA-N 4-chloro-2-fluorobenzoyl chloride Chemical compound FC1=CC(Cl)=CC=C1C(Cl)=O PWHFJLCMUCFYRQ-UHFFFAOYSA-N 0.000 description 1
- ODPJRBXAGAUQAW-UHFFFAOYSA-N 4-chloro-3-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC(C(Cl)=O)=CC=C1Cl ODPJRBXAGAUQAW-UHFFFAOYSA-N 0.000 description 1
- CVNOWLNNPYYEOH-UHFFFAOYSA-N 4-cyanophenol Chemical compound OC1=CC=C(C#N)C=C1 CVNOWLNNPYYEOH-UHFFFAOYSA-N 0.000 description 1
- QCIWHVKGVVQHIY-UHFFFAOYSA-N 4-cyclohexylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1CCCCC1 QCIWHVKGVVQHIY-UHFFFAOYSA-N 0.000 description 1
- YNKHOVDJHNJOOT-UHFFFAOYSA-N 4-ethoxy-N-(2-methoxyethyl)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C(C)OC=1C2=CN(N=C2C=CC1C(=O)NCCOC)CC1CCNCC1 YNKHOVDJHNJOOT-UHFFFAOYSA-N 0.000 description 1
- BRIANBMMGFMPDO-UHFFFAOYSA-N 4-ethyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]indazole-5-carboxylic acid Chemical compound CCc1c(ccc2nn(CC3CCN(CC3)C(=O)OC(C)(C)C)cc12)C(O)=O BRIANBMMGFMPDO-UHFFFAOYSA-N 0.000 description 1
- QZVOCEAFQCQVQB-UHFFFAOYSA-N 4-ethyl-n-(2-methoxyethyl)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(CC)=C(C(=O)NCCOC)C=CC2=NN1CC1CCNCC1 QZVOCEAFQCQVQB-UHFFFAOYSA-N 0.000 description 1
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
- VTFFPXJGTNGKEV-UHFFFAOYSA-N 4-methoxy-N-(2-methoxyethyl)-2-[[1-(1-methylindole-3-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound COC=1C2=CN(N=C2C=CC1C(=O)NCCOC)CC1CCN(CC1)C(=O)C1=CN(C2=CC=CC=C12)C VTFFPXJGTNGKEV-UHFFFAOYSA-N 0.000 description 1
- LBKKUTDCHGVVSG-UHFFFAOYSA-N 4-methoxy-N-(2-methoxyethyl)-2-[[1-[4-(trifluoromethoxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(OC(F)(F)F)cc3)cc2c1OC LBKKUTDCHGVVSG-UHFFFAOYSA-N 0.000 description 1
- KNSQXYBOALVOHB-UHFFFAOYSA-N 4-methoxy-n-(2-methoxyethyl)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC1CCNCC1 KNSQXYBOALVOHB-UHFFFAOYSA-N 0.000 description 1
- DWLBXSSTSTZTMY-UHFFFAOYSA-N 4-methoxy-n-(2-methoxyethyl)-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 DWLBXSSTSTZTMY-UHFFFAOYSA-N 0.000 description 1
- LNAMLLJMYPZZER-UHFFFAOYSA-N 4-methoxy-n-(2-methoxyethyl)-2-[[1-[4-(trifluoromethylsulfanyl)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(OC)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(SC(F)(F)F)C=C1 LNAMLLJMYPZZER-UHFFFAOYSA-N 0.000 description 1
- KXKVLPTZRRBXFD-UHFFFAOYSA-N 4-methyl-2-(piperidin-4-ylmethyl)-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1c(ccc2nn(CC3CCNCC3)cc12)C(=O)NCC(F)(F)F KXKVLPTZRRBXFD-UHFFFAOYSA-N 0.000 description 1
- FUHRPXVXKDMYHY-XJALUBQGSA-N 4-methyl-2-(piperidin-4-ylmethyl)-N-[1,1,2,2-tetradeuterio-2-(trideuteriomethoxy)ethyl]indazole-5-carboxamide Chemical compound CC=1C2=CN(N=C2C=CC=1C(=O)NC(C(OC([2H])([2H])[2H])([2H])[2H])([2H])[2H])CC1CCNCC1 FUHRPXVXKDMYHY-XJALUBQGSA-N 0.000 description 1
- PMGRPUUYIUTWOL-UHFFFAOYSA-N 4-methyl-2-(piperidin-4-ylmethyl)-n-(2-propan-2-yloxyethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)C)C=CC2=NN1CC1CCNCC1 PMGRPUUYIUTWOL-UHFFFAOYSA-N 0.000 description 1
- UBKZHXICUTUKRM-UHFFFAOYSA-N 4-methyl-2-(piperidin-4-ylmethyl)-n-[2-(2,2,2-trifluoroethoxy)ethyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC(F)(F)F)C=CC2=NN1CC1CCNCC1 UBKZHXICUTUKRM-UHFFFAOYSA-N 0.000 description 1
- YGMCMFYAPFGCSV-MRXNPFEDSA-N 4-methyl-2-[[(3R)-1-[4-(trifluoromethoxy)benzoyl]pyrrolidin-3-yl]methyl]-N-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide Chemical compound CC=1C2=CN(N=C2C=CC1C(=O)NCCSC(F)(F)F)C[C@H]1CN(CC1)C(C1=CC=C(C=C1)OC(F)(F)F)=O YGMCMFYAPFGCSV-MRXNPFEDSA-N 0.000 description 1
- PZLGXTYPWOWGCD-UTONKHPSSA-N 4-methyl-2-[[(3R)-pyrrolidin-3-yl]methyl]-N-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1c(ccc2nn(C[C@@H]3CCNC3)cc12)C(=O)NCCSC(F)(F)F PZLGXTYPWOWGCD-UTONKHPSSA-N 0.000 description 1
- DEYMSHAFHSJOCW-CYBMUJFWSA-N 4-methyl-2-[[(3r)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]methyl]indazole-5-carboxylic acid Chemical compound C1=C2C(C)=C(C(O)=O)C=CC2=NN1C[C@@H]1CCN(C(=O)OC(C)(C)C)C1 DEYMSHAFHSJOCW-CYBMUJFWSA-N 0.000 description 1
- BYKWTQNKGJJVKB-UHFFFAOYSA-N 4-methyl-2-[[1-(1-methylbenzimidazole-2-carbonyl)piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=CC=C2N(C)C(C(=O)N3CCC(CC3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCC(F)(F)F)=NC2=C1 BYKWTQNKGJJVKB-UHFFFAOYSA-N 0.000 description 1
- ZUBLJNRMBMTJHA-UHFFFAOYSA-N 4-methyl-2-[[1-(1-methylindole-2-carbonyl)piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=CC=C2N(C)C(C(=O)N3CCC(CC3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCC(F)(F)F)=CC2=C1 ZUBLJNRMBMTJHA-UHFFFAOYSA-N 0.000 description 1
- NCOSPEUIKAXKAG-UHFFFAOYSA-N 4-methyl-2-[[1-(1-methylindole-3-carbonyl)piperidin-4-yl]methyl]-N-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound CN1C=C(C(=O)N2CCC(CN3C=C4C(C=CC(C(=O)NCC(F)(F)F)=C4C)=N3)CC2)C2=CC=CC=C12 NCOSPEUIKAXKAG-UHFFFAOYSA-N 0.000 description 1
- IUWKRNCVVSXSKB-UHFFFAOYSA-N 4-methyl-2-[[1-(2-phenyl-1,3-oxazole-5-carbonyl)piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(O1)=CN=C1C1=CC=CC=C1 IUWKRNCVVSXSKB-UHFFFAOYSA-N 0.000 description 1
- QMNOLXIMQSJVAQ-UHFFFAOYSA-N 4-methyl-2-[[1-(2-phenyl-1,3-thiazole-5-carbonyl)piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(S1)=CN=C1C1=CC=CC=C1 QMNOLXIMQSJVAQ-UHFFFAOYSA-N 0.000 description 1
- LTITZOVDFRKKQR-UHFFFAOYSA-N 4-methyl-2-[[1-(3-phenyl-1,2,4-oxadiazole-5-carbonyl)piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(ON=1)=NC=1C1=CC=CC=C1 LTITZOVDFRKKQR-UHFFFAOYSA-N 0.000 description 1
- OETHIEQINMJPHA-UHFFFAOYSA-N 4-methyl-2-[[1-(5-phenyl-1,3-oxazole-2-carbonyl)piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(O1)=NC=C1C1=CC=CC=C1 OETHIEQINMJPHA-UHFFFAOYSA-N 0.000 description 1
- QXLUTDWRUOEVRM-UHFFFAOYSA-N 4-methyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]methyl]indazole-5-carboxylic acid Chemical compound C1=C2C(C)=C(C(O)=O)C=CC2=NN1CC1CN(C(=O)OC(C)(C)C)C1 QXLUTDWRUOEVRM-UHFFFAOYSA-N 0.000 description 1
- NTJYZQLTGDMXFI-UHFFFAOYSA-N 4-methyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]indazole-5-carboxylic acid Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)OC(C)(C)C)cc12)C(O)=O NTJYZQLTGDMXFI-UHFFFAOYSA-N 0.000 description 1
- FFKZBTYLCRESPP-UHFFFAOYSA-N 4-methyl-2-[[1-[4-(5-methylpyridin-2-yl)benzoyl]piperidin-4-yl]methyl]-n-(2,2,2-trifluoroethyl)indazole-5-carboxamide Chemical compound N1=CC(C)=CC=C1C1=CC=C(C(=O)N2CCC(CN3N=C4C=CC(=C(C)C4=C3)C(=O)NCC(F)(F)F)CC2)C=C1 FFKZBTYLCRESPP-UHFFFAOYSA-N 0.000 description 1
- XWFMQTOWYXKJOU-UHFFFAOYSA-N 4-methyl-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]-N-[2-(trifluoromethylsulfanyl)ethyl]indazole-5-carboxamide Chemical compound CC=1C2=CN(N=C2C=CC1C(=O)NCCSC(F)(F)F)CC1CN(C1)C(C1=CC=C(C=C1)OC(F)(F)F)=O XWFMQTOWYXKJOU-UHFFFAOYSA-N 0.000 description 1
- SCQPMCWZWPZOPH-UHFFFAOYSA-N 4-methyl-N-(2-methylsulfonylethyl)-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound S(=O)(=O)(C)CCNC(=O)C1=C(C2=CN(N=C2C=C1)CC1CCN(CC1)C(C1=CC=C(C=C1)OC1=CC=C(C=C1)C(F)(F)F)=O)C SCQPMCWZWPZOPH-UHFFFAOYSA-N 0.000 description 1
- GGLGLAQNYXHTTK-UHFFFAOYSA-N 4-methyl-N-(2-methylsulfonylethyl)-2-[[1-[4-[6-(trifluoromethyl)pyridin-3-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound S(=O)(=O)(C)CCNC(=O)C1=C(C2=CN(N=C2C=C1)CC1CCN(CC1)C(C1=CC=C(C=C1)OC=1C=NC(=CC1)C(F)(F)F)=O)C GGLGLAQNYXHTTK-UHFFFAOYSA-N 0.000 description 1
- WGPCJEWRCFNJTE-UHFFFAOYSA-N 4-methyl-N-(2-morpholin-4-ylethyl)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1c(ccc2nn(CC3CCNCC3)cc12)C(=O)NCCN1CCOCC1 WGPCJEWRCFNJTE-UHFFFAOYSA-N 0.000 description 1
- YEMALHSKIIBLEY-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-(trifluoromethylsulfanyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(SC(F)(F)F)C=C1 YEMALHSKIIBLEY-UHFFFAOYSA-N 0.000 description 1
- WZQFVCJMYXFTMZ-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[2-(trifluoromethyl)pyrimidin-5-yl]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CN=C(C(F)(F)F)N=C1 WZQFVCJMYXFTMZ-UHFFFAOYSA-N 0.000 description 1
- UIMVIQHCIAWIJB-UHFFFAOYSA-N 4-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-[6-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(F)(F)F)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=CC(C(F)(F)F)=N1 UIMVIQHCIAWIJB-UHFFFAOYSA-N 0.000 description 1
- WFBITSLHKRQFCS-UHFFFAOYSA-N 4-methyl-n-(2-methylpropyl)-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCC(C)C)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 WFBITSLHKRQFCS-UHFFFAOYSA-N 0.000 description 1
- KNYNYUUZQFCFLH-UHFFFAOYSA-N 4-methyl-n-(2-methylsulfonylethyl)-2-[[1-[4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCS(C)(=O)=O)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 KNYNYUUZQFCFLH-UHFFFAOYSA-N 0.000 description 1
- QKWIWMMSDSEARK-UHFFFAOYSA-N 4-methyl-n-(2-morpholin-4-ylethyl)-2-[[1-[3-(trifluoromethoxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=CC(OC(F)(F)F)=C1 QKWIWMMSDSEARK-UHFFFAOYSA-N 0.000 description 1
- STIQHMJKPAMINP-UHFFFAOYSA-N 4-methyl-n-(2-morpholin-4-ylethyl)-2-[[1-[3-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=CC(C(F)(F)F)=C1 STIQHMJKPAMINP-UHFFFAOYSA-N 0.000 description 1
- LCIKMJMRFJDNGB-UHFFFAOYSA-N 4-methyl-n-(2-morpholin-4-ylethyl)-2-[[1-[4-(trifluoromethoxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 LCIKMJMRFJDNGB-UHFFFAOYSA-N 0.000 description 1
- ODAWGGYNURJQIM-UHFFFAOYSA-N 4-methyl-n-(2-morpholin-4-ylethyl)-2-[[1-[4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCN3CCOCC3)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(C(F)(F)F)C=C1 ODAWGGYNURJQIM-UHFFFAOYSA-N 0.000 description 1
- ADKXQNVFROJYDZ-UHFFFAOYSA-N 4-methyl-n-[2-[(2-methylpropan-2-yl)oxy]ethyl]-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC(C)(C)C)C=CC2=NN1CC1CCNCC1 ADKXQNVFROJYDZ-UHFFFAOYSA-N 0.000 description 1
- GKSKQZLHPWBLJL-UHFFFAOYSA-N 4-pyridin-2-yloxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=CC=N1 GKSKQZLHPWBLJL-UHFFFAOYSA-N 0.000 description 1
- JZHQITAPTQQMIF-UHFFFAOYSA-N 4-pyridin-3-yloxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=CC=CN=C1 JZHQITAPTQQMIF-UHFFFAOYSA-N 0.000 description 1
- UCMUIXMNKTUUEV-UHFFFAOYSA-N 4-pyrimidin-2-yloxybenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1OC1=NC=CC=N1 UCMUIXMNKTUUEV-UHFFFAOYSA-N 0.000 description 1
- KDVYCTOWXSLNNI-UHFFFAOYSA-N 4-t-Butylbenzoic acid Chemical compound CC(C)(C)C1=CC=C(C(O)=O)C=C1 KDVYCTOWXSLNNI-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- STVHMYNPQCLUNJ-UHFFFAOYSA-N 5-bromo-1h-indazole Chemical compound BrC1=CC=C2NN=CC2=C1 STVHMYNPQCLUNJ-UHFFFAOYSA-N 0.000 description 1
- RPFAUCIXZGMCFN-UHFFFAOYSA-N 5-bromo-2-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Br)C=N1 RPFAUCIXZGMCFN-UHFFFAOYSA-N 0.000 description 1
- JIOUAWYCKULEAP-UHFFFAOYSA-N 5-bromo-4-(difluoromethoxy)-1h-indazole Chemical compound FC(F)OC1=C(Br)C=CC2=C1C=NN2 JIOUAWYCKULEAP-UHFFFAOYSA-N 0.000 description 1
- NITAZIUYMOVOFU-UHFFFAOYSA-N 5-bromo-4-ethyl-1h-indazole Chemical compound CCC1=C(Br)C=CC2=C1C=NN2 NITAZIUYMOVOFU-UHFFFAOYSA-N 0.000 description 1
- IZLZZNZOCDXQCP-UHFFFAOYSA-N 5-bromo-4-methoxy-1h-indazole Chemical compound COC1=C(Br)C=CC2=C1C=NN2 IZLZZNZOCDXQCP-UHFFFAOYSA-N 0.000 description 1
- GLOTVIAEDAXCAT-UHFFFAOYSA-N 5-bromo-7-methoxy-1h-indazole Chemical compound COC1=CC(Br)=CC2=C1NN=C2 GLOTVIAEDAXCAT-UHFFFAOYSA-N 0.000 description 1
- FTRDLBAPFAIPKC-UHFFFAOYSA-N 6-methyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]methyl]indazole-5-carboxylic acid Chemical compound Cc1cc2nn(CC3CN(C3)C(=O)OC(C)(C)C)cc2cc1C(O)=O FTRDLBAPFAIPKC-UHFFFAOYSA-N 0.000 description 1
- GGNXCBAQVAREQZ-UHFFFAOYSA-N 6-methyl-N-(2,2,2-trifluoroethyl)-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound Cc1cc2nn(CC3CN(C3)C(=O)c3ccc(Oc4ccc(cc4)C(F)(F)F)cc3)cc2cc1C(=O)NCC(F)(F)F GGNXCBAQVAREQZ-UHFFFAOYSA-N 0.000 description 1
- XWLZTXSSHXLUFA-UHFFFAOYSA-N 6-methyl-n-(2,2,2-trifluoroethyl)-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C=C(C(=O)NCC(F)(F)F)C(C)=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 XWLZTXSSHXLUFA-UHFFFAOYSA-N 0.000 description 1
- HPAPZNRMJSCOPV-UHFFFAOYSA-N 6-methyl-n-(2-morpholin-4-ylethyl)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C1=C2C=C(C(=O)NCCN3CCOCC3)C(C)=CC2=NN1CC1CCNCC1 HPAPZNRMJSCOPV-UHFFFAOYSA-N 0.000 description 1
- XOGZMDWQYMEZGT-UHFFFAOYSA-N 6-methyl-n-(2-morpholin-4-ylethyl)-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C=C(C(=O)NCCN3CCOCC3)C(C)=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 XOGZMDWQYMEZGT-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- UNQYAAAWKOOBFQ-UHFFFAOYSA-N 7-[(4-chlorophenyl)methyl]-8-[4-chloro-3-(trifluoromethoxy)phenoxy]-1-(3-hydroxypropyl)-3-methylpurine-2,6-dione Chemical compound C=1C=C(Cl)C=CC=1CN1C=2C(=O)N(CCCO)C(=O)N(C)C=2N=C1OC1=CC=C(Cl)C(OC(F)(F)F)=C1 UNQYAAAWKOOBFQ-UHFFFAOYSA-N 0.000 description 1
- UNFNRIIETORURP-UHFFFAOYSA-N 7-methoxynaphthalen-2-ol Chemical compound C1=CC(O)=CC2=CC(OC)=CC=C21 UNFNRIIETORURP-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 101100481793 Arabidopsis thaliana TOC33 gene Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- MYZMTCNHXVVODE-SPQPEBIOSA-N C(C)(C)(C)N1CCC(CC1)CN1N=C2C=CC(=C(C2=C1)C)C(NC(C(OC([2H])([2H])[2H])([2H])[2H])([2H])[2H])=O Chemical compound C(C)(C)(C)N1CCC(CC1)CN1N=C2C=CC(=C(C2=C1)C)C(NC(C(OC([2H])([2H])[2H])([2H])[2H])([2H])[2H])=O MYZMTCNHXVVODE-SPQPEBIOSA-N 0.000 description 1
- GCNGPNIHZCSYNZ-UHFFFAOYSA-N CC(C(C(C=C1)=C2)=CC(CC(CCC3)CCC3C(c(cc3)ccc3Cl)=O)C2=C)=C1C(NCCOCC(F)(F)F)=O Chemical compound CC(C(C(C=C1)=C2)=CC(CC(CCC3)CCC3C(c(cc3)ccc3Cl)=O)C2=C)=C1C(NCCOCC(F)(F)F)=O GCNGPNIHZCSYNZ-UHFFFAOYSA-N 0.000 description 1
- XQNWUACTTNXVAX-UHFFFAOYSA-N CC(C(C(C=C1)=C2)=CN(CC3CCC4=NC4CC3)C2=C)=C1C(NCC1OCCOC1)=O Chemical compound CC(C(C(C=C1)=C2)=CN(CC3CCC4=NC4CC3)C2=C)=C1C(NCC1OCCOC1)=O XQNWUACTTNXVAX-UHFFFAOYSA-N 0.000 description 1
- OXUNOLGJJWBSSR-UHFFFAOYSA-N CC(C1=CC(CCCC(CC2)CCC2C(C(C2=CC22)=Cc3c2ccc(OC)c3)=O)N=C1C=C1)=C1C(NCC(F)(F)F)=O Chemical compound CC(C1=CC(CCCC(CC2)CCC2C(C(C2=CC22)=Cc3c2ccc(OC)c3)=O)N=C1C=C1)=C1C(NCC(F)(F)F)=O OXUNOLGJJWBSSR-UHFFFAOYSA-N 0.000 description 1
- PERGSXBUKMLCHD-UHFFFAOYSA-N COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(c(F)c3F)-c3ccc(OC)cc3)cc2c1C Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(c(F)c3F)-c3ccc(OC)cc3)cc2c1C PERGSXBUKMLCHD-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- QJQYKRDCUGNCFX-UHFFFAOYSA-N Cc(c1c[n](CC2CCNCC2)nc1cc1)c1C(NCCOC(F)(F)F)=O Chemical compound Cc(c1c[n](CC2CCNCC2)nc1cc1)c1C(NCCOC(F)(F)F)=O QJQYKRDCUGNCFX-UHFFFAOYSA-N 0.000 description 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 description 1
- YGMZWPGLOWIWSO-UHFFFAOYSA-N Cl.C1(CCC1)NNC Chemical compound Cl.C1(CCC1)NNC YGMZWPGLOWIWSO-UHFFFAOYSA-N 0.000 description 1
- LHHBTPLBWLNCTN-UHFFFAOYSA-N ClC1=CC=C(C(=O)N2CC(C2)CN2N(C3=CC=CC(=C3C2)C)CCOC)C=C1 Chemical compound ClC1=CC=C(C(=O)N2CC(C2)CN2N(C3=CC=CC(=C3C2)C)CCOC)C=C1 LHHBTPLBWLNCTN-UHFFFAOYSA-N 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108010011631 Equine Gonadotropins Proteins 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001117305 Homo sapiens Prostaglandin D2 receptor Proteins 0.000 description 1
- 101001073427 Homo sapiens Prostaglandin E2 receptor EP1 subtype Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000282567 Macaca fascicularis Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- FVUGGXCFWDDTNK-UHFFFAOYSA-N N-(2,2-dimethylpropyl)-4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound Cc1c(ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Oc4ccc(cc4)C(F)(F)F)cc3)cc12)C(=O)NCC(C)(C)C FVUGGXCFWDDTNK-UHFFFAOYSA-N 0.000 description 1
- JFZNIJCDZYSFRG-UHFFFAOYSA-N N-(2-cyanoethyl)-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1c(ccc2nn(CC3CCNCC3)cc12)C(=O)NCCC#N JFZNIJCDZYSFRG-UHFFFAOYSA-N 0.000 description 1
- RUQPIRQWAYTMBF-UHFFFAOYSA-N N-(2-methoxyethyl)-2-(piperidin-4-ylmethyl)-4-(2,2,2-trifluoroethoxy)indazole-5-carboxamide hydrochloride Chemical compound Cl.COCCNC(=O)c1ccc2nn(CC3CCNCC3)cc2c1OCC(F)(F)F RUQPIRQWAYTMBF-UHFFFAOYSA-N 0.000 description 1
- JVTKQVVGFHKQET-UHFFFAOYSA-N N-(2-methoxyethyl)-2-[[1-(7-methoxynaphthalene-2-carbonyl)piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc4ccc(OC)cc4c3)cc2c1C JVTKQVVGFHKQET-UHFFFAOYSA-N 0.000 description 1
- FKAUCTHHUFASFG-BTQNPOSSSA-N N-(2-methoxyethyl)-4-methyl-2-[[(3R)-pyrrolidin-3-yl]methyl]indazole-5-carboxamide hydrochloride Chemical compound Cl.COCCNC(=O)c1ccc2nn(C[C@@H]3CCNC3)cc2c1C FKAUCTHHUFASFG-BTQNPOSSSA-N 0.000 description 1
- XCGAQXQGWXFQTN-NRFANRHFSA-N N-(2-methoxyethyl)-4-methyl-2-[[(3S)-1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]pyrrolidin-3-yl]methyl]indazole-5-carboxamide Chemical compound COCCNC(=O)c1ccc2nn(C[C@H]3CCN(C3)C(=O)c3ccc(Oc4ccc(cc4)C(F)(F)F)cc3)cc2c1C XCGAQXQGWXFQTN-NRFANRHFSA-N 0.000 description 1
- FKAUCTHHUFASFG-ZOWNYOTGSA-N N-(2-methoxyethyl)-4-methyl-2-[[(3S)-pyrrolidin-3-yl]methyl]indazole-5-carboxamide hydrochloride Chemical compound Cl.COCCNC(=O)c1ccc2nn(C[C@H]3CCNC3)cc2c1C FKAUCTHHUFASFG-ZOWNYOTGSA-N 0.000 description 1
- IVYVOCQRQDZRFZ-UHFFFAOYSA-N N-(2-methoxyethyl)-4-methyl-2-[[1-(1-methylindole-3-carbonyl)azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound COCCNC(=O)C1=C(C2=CN(N=C2C=C1)CC1CN(C1)C(=O)C1=CN(C2=CC=CC=C12)C)C IVYVOCQRQDZRFZ-UHFFFAOYSA-N 0.000 description 1
- CQXHMINMCSZENS-UHFFFAOYSA-N N-(2-methoxyethyl)-6-methyl-2-[[1-[4-(trifluoromethoxy)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound COCCNC(=O)c1cc2cn(CC3CN(C3)C(=O)c3ccc(OC(F)(F)F)cc3)nc2cc1C CQXHMINMCSZENS-UHFFFAOYSA-N 0.000 description 1
- ZIXBOFLZFFMGBN-UHFFFAOYSA-N N-(2-methoxyethyl)-6-methyl-2-[[1-[4-(trifluoromethyl)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound COCCNC(=O)c1cc2cn(CC3CN(C3)C(=O)c3ccc(cc3)C(F)(F)F)nc2cc1C ZIXBOFLZFFMGBN-UHFFFAOYSA-N 0.000 description 1
- SLMXHTUYGWUZOZ-UHFFFAOYSA-N N-(2-methoxyethyl)-6-methyl-2-[[1-[4-(trifluoromethyl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound COCCNC(=O)c1cc2cn(CC3CCN(CC3)C(=O)c3ccc(cc3)C(F)(F)F)nc2cc1C SLMXHTUYGWUZOZ-UHFFFAOYSA-N 0.000 description 1
- XNFLWEDFGPDNRI-UHFFFAOYSA-N N-(2-methoxyethyl)-6-methyl-2-[[1-[4-(trifluoromethylsulfanyl)benzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound COCCNC(=O)C1=CC2=CN(N=C2C=C1C)CC1CN(C1)C(C1=CC=C(C=C1)SC(F)(F)F)=O XNFLWEDFGPDNRI-UHFFFAOYSA-N 0.000 description 1
- IREFQWWJHBCLOR-UHFFFAOYSA-N N-(3-hydroxypropyl)-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1c(ccc2nn(CC3CCNCC3)cc12)C(=O)NCCCO IREFQWWJHBCLOR-UHFFFAOYSA-N 0.000 description 1
- OWGMSLNFOHFFOF-UHFFFAOYSA-N N-(cyanomethyl)-4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C(#N)CNC(=O)C1=C(C2=CN(N=C2C=C1)CC1CCN(CC1)C(C1=CC=C(C=C1)OC1=CC=C(C=C1)C(F)(F)F)=O)C OWGMSLNFOHFFOF-UHFFFAOYSA-N 0.000 description 1
- AWUDIAXHWSMJSI-UHFFFAOYSA-N N-[2-(3,3-difluoropyrrolidin-1-yl)ethyl]-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide hydrochloride Chemical compound Cl.Cc1c(ccc2nn(CC3CCNCC3)cc12)C(=O)NCCN1CCC(F)(F)C1 AWUDIAXHWSMJSI-UHFFFAOYSA-N 0.000 description 1
- MQYHCSQFPGLVAX-UHFFFAOYSA-N N-[2-(cyclopropylmethoxy)ethyl]-2-[[1-[4-(4-fluorophenyl)benzoyl]piperidin-2-yl]methyl]-4-(2,2,2-trifluoroethoxy)indazole-5-carboxamide Chemical compound C1(CC1)COCCNC(=O)C1=C(C2=CN(N=C2C=C1)CC1N(CCCC1)C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)F)OCC(F)(F)F MQYHCSQFPGLVAX-UHFFFAOYSA-N 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 208000011707 Ovulation disease Diseases 0.000 description 1
- 101150053131 PTGER3 gene Proteins 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108050000258 Prostaglandin D receptors Proteins 0.000 description 1
- 102000009389 Prostaglandin D receptors Human genes 0.000 description 1
- 102100035842 Prostaglandin E2 receptor EP1 subtype Human genes 0.000 description 1
- 102100024447 Prostaglandin E2 receptor EP3 subtype Human genes 0.000 description 1
- 102100024450 Prostaglandin E2 receptor EP4 subtype Human genes 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 1
- 101150109738 Ptger4 gene Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 description 1
- BNXBFDTWYHAEIR-UHFFFAOYSA-N [4-(2-cyanopropan-2-yl)phenyl]boronic acid Chemical compound N#CC(C)(C)C1=CC=C(B(O)O)C=C1 BNXBFDTWYHAEIR-UHFFFAOYSA-N 0.000 description 1
- SFBQNNGMEKUJAN-UHFFFAOYSA-N [5-(trifluoromethyl)pyridin-3-yl]boronic acid Chemical compound OB(O)C1=CN=CC(C(F)(F)F)=C1 SFBQNNGMEKUJAN-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- DFNYGALUNNFWKJ-UHFFFAOYSA-N aminoacetonitrile Chemical compound NCC#N DFNYGALUNNFWKJ-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 230000002513 anti-ovulatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 150000001543 aryl boronic acids Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- GIUHQHXEXPNYJT-UHFFFAOYSA-N azetidin-1-yl-[4-[4-(trifluoromethyl)phenoxy]phenyl]methanone Chemical compound FC(C1=CC=C(OC2=CC=C(C(=O)N3CCC3)C=C2)C=C1)(F)F GIUHQHXEXPNYJT-UHFFFAOYSA-N 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 125000004931 azocinyl group Chemical group N1=C(C=CC=CC=C1)* 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940029106 celecoxib 400 mg Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940124558 contraceptive agent Drugs 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- JVZOVVGVPJVLSL-UHFFFAOYSA-N cyclobutylmethanamine;hydron;chloride Chemical compound Cl.NCC1CCC1 JVZOVVGVPJVLSL-UHFFFAOYSA-N 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- YOXHCYXIAVIFCZ-UHFFFAOYSA-N cyclopropanol Chemical compound OC1CC1 YOXHCYXIAVIFCZ-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000000131 cyclopropyloxy group Chemical group C1(CC1)O* 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- AAXGWYDSLJUQLN-UHFFFAOYSA-N diphenyl(propyl)phosphane Chemical compound C=1C=CC=CC=1P(CCC)C1=CC=CC=C1 AAXGWYDSLJUQLN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 229940095053 emergency contraceptive drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000003687 estradiol congener Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PKWIYNIDEDLDCJ-UHFFFAOYSA-N guanazole Chemical compound NC1=NNC(N)=N1 PKWIYNIDEDLDCJ-UHFFFAOYSA-N 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 231100000546 inhibition of ovulation Toxicity 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- INQOMBQAUSQDDS-BJUDXGSMSA-N iodomethane Chemical class I[11CH3] INQOMBQAUSQDDS-BJUDXGSMSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 210000004731 jugular vein Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 238000013187 longer-term treatment Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000005905 mesyloxy group Chemical group 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- AWAYJQJPQHDHRK-UHFFFAOYSA-N methyl 2-(azetidin-3-ylmethyl)-4-methoxyindazole-5-carboxylate Chemical compound C1=C2C(OC)=C(C(=O)OC)C=CC2=NN1CC1CNC1 AWAYJQJPQHDHRK-UHFFFAOYSA-N 0.000 description 1
- PSRIFPJUUDHNRS-UHFFFAOYSA-N methyl 2-[[1-(4-chlorobenzoyl)azetidin-3-yl]methyl]-4-methoxyindazole-5-carboxylate Chemical compound C1=C2C(OC)=C(C(=O)OC)C=CC2=NN1CC(C1)CN1C(=O)C1=CC=C(Cl)C=C1 PSRIFPJUUDHNRS-UHFFFAOYSA-N 0.000 description 1
- MDWODNUPBYPTNG-UHFFFAOYSA-N methyl 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methoxyindazole-5-carboxylate Chemical compound COC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)c3ccc(Cl)cc3)cc2c1OC MDWODNUPBYPTNG-UHFFFAOYSA-N 0.000 description 1
- AXWKLELVMOZKKR-UHFFFAOYSA-N methyl 2-[[1-(4-chlorobenzoyl)piperidin-4-yl]methyl]-4-methylindazole-5-carboxylate Chemical compound C1=C2C(C)=C(C(=O)OC)C=CC2=NN1CC(CC1)CCN1C(=O)C1=CC=C(Cl)C=C1 AXWKLELVMOZKKR-UHFFFAOYSA-N 0.000 description 1
- XVNDRNOUPKTUJS-UHFFFAOYSA-N methyl 2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]-4-(2,2,2-trifluoroethoxy)indazole-5-carboxylate Chemical compound COC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)OC(C)(C)C)cc2c1OCC(F)(F)F XVNDRNOUPKTUJS-UHFFFAOYSA-N 0.000 description 1
- DKDAQGWLUPUPFS-UHFFFAOYSA-N methyl 4-(difluoromethoxy)-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]indazole-5-carboxylate Chemical compound COC(=O)c1ccc2nn(CC3CCN(CC3)C(=O)OC(C)(C)C)cc2c1OC(F)F DKDAQGWLUPUPFS-UHFFFAOYSA-N 0.000 description 1
- XXBRWTVSXIXADN-UHFFFAOYSA-N methyl 4-ethyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]indazole-5-carboxylate Chemical compound CCc1c(ccc2nn(CC3CCN(CC3)C(=O)OC(C)(C)C)cc12)C(=O)OC XXBRWTVSXIXADN-UHFFFAOYSA-N 0.000 description 1
- WCMUCPAZLBHPAI-UHFFFAOYSA-N methyl 4-methoxy-2-(piperidin-4-ylmethyl)indazole-5-carboxylate Chemical compound COC(=O)c1ccc2nn(CC3CCNCC3)cc2c1OC WCMUCPAZLBHPAI-UHFFFAOYSA-N 0.000 description 1
- ZAPALQDYYYWQQZ-UHFFFAOYSA-N methyl 4-methoxy-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]indazole-5-carboxylate Chemical compound C1=C2C(OC)=C(C(=O)OC)C=CC2=NN1CC1CCN(C(=O)OC(C)(C)C)CC1 ZAPALQDYYYWQQZ-UHFFFAOYSA-N 0.000 description 1
- CWIZTSQNPLMLAM-UHFFFAOYSA-N methyl 4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxylate;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)OC)C=CC2=NN1CC1CCNCC1 CWIZTSQNPLMLAM-UHFFFAOYSA-N 0.000 description 1
- JOCOWTCRBDAYIJ-CQSZACIVSA-N methyl 4-methyl-2-[[(3r)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-3-yl]methyl]indazole-5-carboxylate Chemical compound C1=C2C(C)=C(C(=O)OC)C=CC2=NN1C[C@@H]1CCN(C(=O)OC(C)(C)C)C1 JOCOWTCRBDAYIJ-CQSZACIVSA-N 0.000 description 1
- QDDVCHKDDZGSNR-UHFFFAOYSA-N methyl 4-methyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]methyl]indazole-5-carboxylate Chemical compound C1=C2C(C)=C(C(=O)OC)C=CC2=NN1CC1CN(C(=O)OC(C)(C)C)C1 QDDVCHKDDZGSNR-UHFFFAOYSA-N 0.000 description 1
- AUHJIEHOMCGWIA-UHFFFAOYSA-N methyl 4-methyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]methyl]indazole-5-carboxylate Chemical compound COC(=O)C1=C(C)C2=CN(CC3CCN(CC3)C(=O)OC(C)(C)C)N=C2C=C1 AUHJIEHOMCGWIA-UHFFFAOYSA-N 0.000 description 1
- WFFZUQGVFXXRGH-UHFFFAOYSA-N methyl 6-methyl-2-[[1-[(2-methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]methyl]indazole-5-carboxylate Chemical compound COC(=O)c1cc2cn(CC3CN(C3)C(=O)OC(C)(C)C)nc2cc1C WFFZUQGVFXXRGH-UHFFFAOYSA-N 0.000 description 1
- FCGMYOHQMJECKJ-UHFFFAOYSA-N methyl 7-methoxynaphthalene-2-carboxylate Chemical compound C1=CC(OC)=CC2=CC(C(=O)OC)=CC=C21 FCGMYOHQMJECKJ-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- YKFLJYAKACCWMH-UHFFFAOYSA-N methyl piperidine-1-carboxylate Chemical compound COC(=O)N1CCCCC1 YKFLJYAKACCWMH-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 229940110234 mirena Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- JHWWHFFWVOMDRU-UHFFFAOYSA-N n-(2-cyanoethyl)-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCC#N)C=CC2=NN1CC1CCNCC1 JHWWHFFWVOMDRU-UHFFFAOYSA-N 0.000 description 1
- HTSTZQJHOYNMPS-UHFFFAOYSA-N n-(2-cyanoethyl)-4-methyl-2-[[1-[4-[4-(trifluoromethyl)phenoxy]benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCC#N)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=C1 HTSTZQJHOYNMPS-UHFFFAOYSA-N 0.000 description 1
- RTUUMHYWSKNVMS-UHFFFAOYSA-N n-(2-hydroxyethyl)-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCO)C=CC2=NN1CC1CCNCC1 RTUUMHYWSKNVMS-UHFFFAOYSA-N 0.000 description 1
- IIKVDHRUDORJMV-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-(6-methoxynaphthalene-2-carbonyl)azetidin-3-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C(OC)C=CC2=CC(C(=O)N3CC(C3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCCOC)=CC=C21 IIKVDHRUDORJMV-UHFFFAOYSA-N 0.000 description 1
- FFUHKKHWVBOVPD-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-(6-methoxynaphthalene-2-carbonyl)piperidin-4-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=C(OC)C=CC2=CC(C(=O)N3CCC(CC3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCCOC)=CC=C21 FFUHKKHWVBOVPD-UHFFFAOYSA-N 0.000 description 1
- HSEIHNIHPLXXIV-UHFFFAOYSA-N n-(2-methoxyethyl)-2-[[1-(7-methoxynaphthalene-2-carbonyl)azetidin-3-yl]methyl]-4-methylindazole-5-carboxamide Chemical compound C1=CC(OC)=CC2=CC(C(=O)N3CC(C3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCCOC)=CC=C21 HSEIHNIHPLXXIV-UHFFFAOYSA-N 0.000 description 1
- AURGMLDTIDESTF-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC1CCNCC1 AURGMLDTIDESTF-UHFFFAOYSA-N 0.000 description 1
- SRNOBIVZNGOBMF-QGZVFWFLSA-N n-(2-methoxyethyl)-4-methyl-2-[[(3r)-1-[4-(trifluoromethoxy)benzoyl]pyrrolidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C([C@H](C1)CN2N=C3C=CC(=C(C3=C2)C)C(=O)NCCOC)CN1C(=O)C1=CC=C(OC(F)(F)F)C=C1 SRNOBIVZNGOBMF-QGZVFWFLSA-N 0.000 description 1
- ZTJKVDWJHCCDSJ-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(1-methylbenzimidazole-2-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=CC=C2N(C)C(C(=O)N3CCC(CC3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCCOC)=NC2=C1 ZTJKVDWJHCCDSJ-UHFFFAOYSA-N 0.000 description 1
- KYKJMICZTOUMPM-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(1-methylindole-3-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=CC=C2C(C(=O)N3CCC(CC3)CN3N=C4C=CC(=C(C4=C3)C)C(=O)NCCOC)=CN(C)C2=C1 KYKJMICZTOUMPM-UHFFFAOYSA-N 0.000 description 1
- JCEQEWPDTFSSJZ-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(2-phenyl-1,3-oxazole-5-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(O1)=CN=C1C1=CC=CC=C1 JCEQEWPDTFSSJZ-UHFFFAOYSA-N 0.000 description 1
- NXIKQVOUWNZUQC-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(2-phenyl-1,3-thiazole-5-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(S1)=CN=C1C1=CC=CC=C1 NXIKQVOUWNZUQC-UHFFFAOYSA-N 0.000 description 1
- PFERHRUJCMEGBW-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(3-phenyl-1,2,4-oxadiazole-5-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(ON=1)=NC=1C1=CC=CC=C1 PFERHRUJCMEGBW-UHFFFAOYSA-N 0.000 description 1
- PFPYSNAQLDRTKD-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(4-pyridin-4-yloxybenzoyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=NC=C1 PFPYSNAQLDRTKD-UHFFFAOYSA-N 0.000 description 1
- LKPPWAZCIYHESE-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-(5-phenyl-1,3-oxazole-2-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(O1)=NC=C1C1=CC=CC=C1 LKPPWAZCIYHESE-UHFFFAOYSA-N 0.000 description 1
- OOIYZRQLCUWHEP-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(1,2,4-triazol-1-yl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1N1C=NC=N1 OOIYZRQLCUWHEP-UHFFFAOYSA-N 0.000 description 1
- MQGIBRWBLDLCJD-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(1,2-oxazol-5-yl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CC=NO1 MQGIBRWBLDLCJD-UHFFFAOYSA-N 0.000 description 1
- XKVHEEIBZKIWEM-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(1,3-oxazol-2-yl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=NC=CO1 XKVHEEIBZKIWEM-UHFFFAOYSA-N 0.000 description 1
- UMDSANQOCLMUDT-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-(1,3-oxazol-5-yl)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1C1=CN=CO1 UMDSANQOCLMUDT-UHFFFAOYSA-N 0.000 description 1
- PWNNMTNUKOSXNB-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-2-[[1-[4-[5-(trifluoromethyl)pyridin-2-yl]oxybenzoyl]azetidin-3-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOC)C=CC2=NN1CC(C1)CN1C(=O)C(C=C1)=CC=C1OC1=CC=C(C(F)(F)F)C=N1 PWNNMTNUKOSXNB-UHFFFAOYSA-N 0.000 description 1
- UBBUZUPGIUXYAY-UHFFFAOYSA-N n-(2-methoxyethyl)-6-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.N1=C2C=C(C)C(C(=O)NCCOC)=CC2=CN1CC1CCNCC1 UBBUZUPGIUXYAY-UHFFFAOYSA-N 0.000 description 1
- JEVFXSJCAXFKBI-UHFFFAOYSA-N n-(2-methoxyethyl)-6-methyl-2-[[1-(1-methylindole-3-carbonyl)piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=CC=C2C(C(=O)N3CCC(CC3)CN3C=C4C=C(C(=CC4=N3)C)C(=O)NCCOC)=CN(C)C2=C1 JEVFXSJCAXFKBI-UHFFFAOYSA-N 0.000 description 1
- BNKSCPAJYDAXIS-UHFFFAOYSA-N n-(3-hydroxypropyl)-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCCO)C=CC2=NN1CC1CCNCC1 BNKSCPAJYDAXIS-UHFFFAOYSA-N 0.000 description 1
- DPBXAYHFONXJGG-UHFFFAOYSA-N n-(4-bromo-3-ethyl-2-methylphenyl)acetamide Chemical compound CCC1=C(Br)C=CC(NC(C)=O)=C1C DPBXAYHFONXJGG-UHFFFAOYSA-N 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- GCDRMWTYTFGHGQ-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-2-(piperidin-4-ylmethyl)-4-(2,2,2-trifluoroethoxy)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(OCC(F)(F)F)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC1CCNCC1 GCDRMWTYTFGHGQ-UHFFFAOYSA-N 0.000 description 1
- GMHMGIUIQKYBFC-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-4-(difluoromethoxy)-2-(piperidin-4-ylmethyl)indazole-5-carboxamide;hydrochloride Chemical compound Cl.C1=C2C(OC(F)F)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC1CCNCC1 GMHMGIUIQKYBFC-UHFFFAOYSA-N 0.000 description 1
- CSCXWDAMXCMYEN-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-4-(difluoromethoxy)-2-[[1-[4-(4-fluorophenoxy)benzoyl]piperidin-4-yl]methyl]indazole-5-carboxamide Chemical compound C1=C2C(OC(F)F)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC(CC1)CCN1C(=O)C(C=C1)=CC=C1OC1=CC=C(F)C=C1 CSCXWDAMXCMYEN-UHFFFAOYSA-N 0.000 description 1
- RAAPMYRMMLYVLA-UHFFFAOYSA-N n-[2-(cyclopropylmethoxy)ethyl]-4-methyl-2-(piperidin-4-ylmethyl)indazole-5-carboxamide Chemical compound C1=C2C(C)=C(C(=O)NCCOCC3CC3)C=CC2=NN1CC1CCNCC1 RAAPMYRMMLYVLA-UHFFFAOYSA-N 0.000 description 1
- LNNRWYMIKKMZSV-UHFFFAOYSA-N n-[4-bromo-2-methyl-3-(2,2,2-trifluoroethoxy)phenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Br)C(OCC(F)(F)F)=C1C LNNRWYMIKKMZSV-UHFFFAOYSA-N 0.000 description 1
- BSQLXUDKHHCGJN-UHFFFAOYSA-N n-[4-bromo-3-(difluoromethoxy)-2-methylphenyl]acetamide Chemical compound CC(=O)NC1=CC=C(Br)C(OC(F)F)=C1C BSQLXUDKHHCGJN-UHFFFAOYSA-N 0.000 description 1
- VFBILHPIHUPBPZ-UHFFFAOYSA-N n-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide Chemical compound CCOC1=CC=CC=C1C(=O)NCC1=COC(C=2C=C(OC(C)C)C(OC(F)F)=CC=2)=N1 VFBILHPIHUPBPZ-UHFFFAOYSA-N 0.000 description 1
- DOWVMJFBDGWVML-UHFFFAOYSA-N n-cyclohexyl-n-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide Chemical compound C1=NC(C=2C=[N+]([O-])C=CC=2)=CN1C(=O)N(C)C1CCCCC1 DOWVMJFBDGWVML-UHFFFAOYSA-N 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- MWOUGPLLVVEUMM-UHFFFAOYSA-N n-ethyl-2-methylaniline Chemical compound CCNC1=CC=CC=C1C MWOUGPLLVVEUMM-UHFFFAOYSA-N 0.000 description 1
- XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229940053934 norethindrone Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- RNVCVTLRINQCPJ-UHFFFAOYSA-N ortho-methyl aniline Natural products CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000011599 ovarian follicle development Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- QDEFNAHLCTUWAH-UHFFFAOYSA-N oxetan-2-ylmethanamine Chemical compound NCC1CCO1 QDEFNAHLCTUWAH-UHFFFAOYSA-N 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- JGTNAGYHADQMCM-UHFFFAOYSA-N perfluorobutanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F JGTNAGYHADQMCM-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- OZIPYILPUGIUIY-UHFFFAOYSA-N piperidin-1-yl-[4-[6-(trifluoromethyl)pyridin-2-yl]phenyl]methanone Chemical compound FC(C1=CC=CC(=N1)C1=CC=C(C(=O)N2CCCCC2)C=C1)(F)F OZIPYILPUGIUIY-UHFFFAOYSA-N 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 239000003408 postcoitus contraceptive agent Substances 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 101150031304 ppi1 gene Proteins 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 239000000044 progesterone antagonist Substances 0.000 description 1
- 150000003145 progesterone derivatives Chemical class 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BHMBVRSPMRCCGG-OUTUXVNYSA-N prostaglandin D2 Chemical compound CCCCC[C@H](O)\C=C\[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@@H](O)CC1=O BHMBVRSPMRCCGG-OUTUXVNYSA-N 0.000 description 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
- BHMBVRSPMRCCGG-UHFFFAOYSA-N prostaglandine D2 Natural products CCCCCC(O)C=CC1C(CC=CCCCC(O)=O)C(O)CC1=O BHMBVRSPMRCCGG-UHFFFAOYSA-N 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical compound OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 1
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 230000031567 regulation of fertilization Effects 0.000 description 1
- 230000031777 regulation of ovulation Effects 0.000 description 1
- 230000027272 reproductive process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- DGICPZNQHQMHHD-MRXNPFEDSA-N tert-butyl (3R)-3-[[5-(2-methoxyethylcarbamoyl)-4-methylindazol-2-yl]methyl]pyrrolidine-1-carboxylate Chemical compound COCCNC(=O)c1ccc2nn(C[C@@H]3CCN(C3)C(=O)OC(C)(C)C)cc2c1C DGICPZNQHQMHHD-MRXNPFEDSA-N 0.000 description 1
- DGICPZNQHQMHHD-INIZCTEOSA-N tert-butyl (3S)-3-[[5-(2-methoxyethylcarbamoyl)-4-methylindazol-2-yl]methyl]pyrrolidine-1-carboxylate Chemical compound COCCNC(=O)c1ccc2nn(C[C@H]3CCN(C3)C(=O)OC(C)(C)C)cc2c1C DGICPZNQHQMHHD-INIZCTEOSA-N 0.000 description 1
- HKIGXXRMJFUUKV-MRVPVSSYSA-N tert-butyl (3r)-3-(hydroxymethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC[C@@H](CO)C1 HKIGXXRMJFUUKV-MRVPVSSYSA-N 0.000 description 1
- WPYAOABDDALQSO-CQSZACIVSA-N tert-butyl (3r)-3-[(4-methylphenyl)sulfonyloxymethyl]pyrrolidine-1-carboxylate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC[C@H]1CN(C(=O)OC(C)(C)C)CC1 WPYAOABDDALQSO-CQSZACIVSA-N 0.000 description 1
- HKIGXXRMJFUUKV-QMMMGPOBSA-N tert-butyl (3s)-3-(hydroxymethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC[C@H](CO)C1 HKIGXXRMJFUUKV-QMMMGPOBSA-N 0.000 description 1
- CJVGFEARJOREHI-UHFFFAOYSA-N tert-butyl 3-(iodomethyl)azetidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CC(CI)C1 CJVGFEARJOREHI-UHFFFAOYSA-N 0.000 description 1
- YGJXBTRLYHCWGD-UHFFFAOYSA-N tert-butyl 4-(bromomethyl)piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CBr)CC1 YGJXBTRLYHCWGD-UHFFFAOYSA-N 0.000 description 1
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical class CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 description 1
- XLXBFUWZBZFCIL-UHFFFAOYSA-N tert-butyl n-(2-cyclobutyloxypropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCC(C)OC1CCC1 XLXBFUWZBZFCIL-UHFFFAOYSA-N 0.000 description 1
- IOGXOCVLYRDXLW-UHFFFAOYSA-N tert-butyl nitrite Chemical compound CC(C)(C)ON=O IOGXOCVLYRDXLW-UHFFFAOYSA-N 0.000 description 1
- 239000012414 tert-butyl nitrite Substances 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000006213 vaginal ring Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020157032972A KR20160014598A (ko) | 2013-05-23 | 2014-05-16 | 제약 조성물 및 그의 용도, 및 필요시 피임을 위한 상기 제약 조성물의 적용 요법 |
TN2015000511A TN2015000511A1 (en) | 2013-05-23 | 2014-05-16 | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
AU2014270596A AU2014270596A1 (en) | 2013-05-23 | 2014-05-16 | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
EA201592207A EA201592207A1 (ru) | 2013-05-23 | 2014-05-16 | Фармацевтическая композиция и ее применение, а также режим применения указанной фармацевтической композиции для контрацепции по мере необходимости ("on-demand") |
CA2913085A CA2913085A1 (en) | 2013-05-23 | 2014-05-16 | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
MX2015016121A MX2015016121A (es) | 2013-05-23 | 2014-05-16 | Composicion farmaceutica, su uso y regimen de administracion para contracepcion a demanda. |
CN201480041669.3A CN105451737B (zh) | 2013-05-23 | 2014-05-16 | 药物组合物及其用途以及所述药物组合物用于按需避孕的施用方法 |
MA38606A MA38606A1 (fr) | 2013-05-23 | 2014-05-16 | Composition pharmaceutique et son utilisation, ainsi que schéma d'emploi de cette composition pharmaceutique pour la contraception à la demande |
AP2015008855A AP2015008855A0 (en) | 2013-05-23 | 2014-05-16 | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
BR112015029214A BR112015029214A2 (pt) | 2013-05-23 | 2014-05-16 | composição farmacêutica, seu uso e regime de aplicação dessa composição farmacêutica para contracepção conforme a necessidade |
EP14724746.4A EP2999469A1 (de) | 2013-05-23 | 2014-05-16 | Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen ( on-demand") kontrazeption |
US14/893,508 US9655887B2 (en) | 2013-05-23 | 2014-05-16 | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
JP2016514342A JP6370887B2 (ja) | 2013-05-23 | 2014-05-16 | オンデマンド避妊のための医薬組成物およびその使用、ならびにこの医薬組成物の適用体制 |
PH12015502598A PH12015502598A1 (en) | 2013-05-23 | 2015-11-16 | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
HK16105550.3A HK1217640A1 (zh) | 2013-05-23 | 2016-05-16 | 藥物組合物及其用途以及所述藥物組合物用於按需避孕的施用方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13169029.9 | 2013-05-23 | ||
EP13169029 | 2013-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2014187744A1 true WO2014187744A1 (de) | 2014-11-27 |
Family
ID=48463871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2014/060103 WO2014187744A1 (de) | 2013-05-23 | 2014-05-16 | Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen („on-demand") kontrazeption |
Country Status (20)
Country | Link |
---|---|
US (1) | US9655887B2 (de) |
EP (1) | EP2999469A1 (de) |
JP (1) | JP6370887B2 (de) |
KR (1) | KR20160014598A (de) |
CN (1) | CN105451737B (de) |
AP (1) | AP2015008855A0 (de) |
AR (1) | AR096386A1 (de) |
AU (1) | AU2014270596A1 (de) |
BR (1) | BR112015029214A2 (de) |
CA (1) | CA2913085A1 (de) |
CL (1) | CL2015003434A1 (de) |
EA (1) | EA201592207A1 (de) |
HK (1) | HK1217640A1 (de) |
MA (1) | MA38606A1 (de) |
MX (1) | MX2015016121A (de) |
PH (1) | PH12015502598A1 (de) |
TN (1) | TN2015000511A1 (de) |
TW (1) | TW201522325A (de) |
UY (1) | UY35584A (de) |
WO (1) | WO2014187744A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210003166A (ko) | 2018-04-17 | 2021-01-11 | 템페스트 테라퓨틱스, 인크. | 비시클릭 카르복스아미드 및 그의 사용 방법 |
CN110215447A (zh) * | 2019-06-14 | 2019-09-10 | 上海市计划生育科学研究所 | 甲芬那酸在避孕药物中的应用及其制备的杀精避孕药物 |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996012494A1 (de) | 1994-10-24 | 1996-05-02 | Schering Aktiengesellschaft | Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle |
US20040058975A1 (en) * | 2002-06-26 | 2004-03-25 | Schering Ag | Method for fertility control |
EP1448207A1 (de) | 2001-11-27 | 2004-08-25 | Richter Gedeon Vegyeszeti Gyar R.T. | Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung |
WO2006104406A1 (en) | 2005-03-31 | 2006-10-05 | Auckland Uniservices Limited | Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
WO2007045513A1 (de) | 2005-10-19 | 2007-04-26 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur präventiven bedarsweisen hormonalen kontrazeption |
WO2007091107A1 (en) | 2006-02-10 | 2007-08-16 | Summit Corporation Plc | Treatment of duchenne muscular dystrophy |
WO2008070599A1 (en) | 2006-12-05 | 2008-06-12 | Chung-Ming Sun | Indazole compounds |
WO2010119029A1 (en) | 2009-04-14 | 2010-10-21 | Laboratoire Hra-Pharma | Method for on-demand contraception |
WO2010119030A1 (en) | 2009-04-14 | 2010-10-21 | Ulmann Andre | Method for on-demand contraception using levonorgestrel or norgestrel |
WO2010124102A1 (en) | 2009-04-22 | 2010-10-28 | Janssen Pharmaceutica Nv | Azetidinyl diamides as monoacylglycerol lipase inhibitors |
WO2010149273A1 (de) | 2009-06-23 | 2010-12-29 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische zusammensetzung zur notfallempfängnisverhütung |
DE102009049662A1 (de) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten |
WO2011069871A1 (en) | 2009-12-09 | 2011-06-16 | Laboratoire Hra-Pharma | A method for providing emergency contraception using ulipristal acetate |
WO2011091892A1 (en) | 2010-02-01 | 2011-08-04 | Ulmann Andre | A method for late post coital contraception using ulipristal acetate |
WO2013079425A1 (en) * | 2011-11-28 | 2013-06-06 | Bayer Intellectual Property Gmbh | Novel 2h-indazoles as ep2 receptor antagonists |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009063365A1 (en) * | 2007-11-15 | 2009-05-22 | Pfizer Limited | Azetidines as ep2 antagonists |
-
2014
- 2014-05-16 KR KR1020157032972A patent/KR20160014598A/ko not_active Application Discontinuation
- 2014-05-16 BR BR112015029214A patent/BR112015029214A2/pt not_active IP Right Cessation
- 2014-05-16 US US14/893,508 patent/US9655887B2/en not_active Expired - Fee Related
- 2014-05-16 WO PCT/EP2014/060103 patent/WO2014187744A1/de active Application Filing
- 2014-05-16 EA EA201592207A patent/EA201592207A1/ru unknown
- 2014-05-16 EP EP14724746.4A patent/EP2999469A1/de not_active Withdrawn
- 2014-05-16 MA MA38606A patent/MA38606A1/fr unknown
- 2014-05-16 MX MX2015016121A patent/MX2015016121A/es unknown
- 2014-05-16 JP JP2016514342A patent/JP6370887B2/ja not_active Expired - Fee Related
- 2014-05-16 AU AU2014270596A patent/AU2014270596A1/en not_active Abandoned
- 2014-05-16 TN TN2015000511A patent/TN2015000511A1/en unknown
- 2014-05-16 AP AP2015008855A patent/AP2015008855A0/xx unknown
- 2014-05-16 CN CN201480041669.3A patent/CN105451737B/zh not_active Expired - Fee Related
- 2014-05-16 CA CA2913085A patent/CA2913085A1/en not_active Abandoned
- 2014-05-21 TW TW103117811A patent/TW201522325A/zh unknown
- 2014-05-22 AR ARP140102027A patent/AR096386A1/es unknown
- 2014-05-23 UY UY0001035584A patent/UY35584A/es not_active Application Discontinuation
-
2015
- 2015-11-16 PH PH12015502598A patent/PH12015502598A1/en unknown
- 2015-11-23 CL CL2015003434A patent/CL2015003434A1/es unknown
-
2016
- 2016-05-16 HK HK16105550.3A patent/HK1217640A1/zh unknown
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996012494A1 (de) | 1994-10-24 | 1996-05-02 | Schering Aktiengesellschaft | Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle |
EP1448207A1 (de) | 2001-11-27 | 2004-08-25 | Richter Gedeon Vegyeszeti Gyar R.T. | Behandlungsverfahren und pharmazeutische zusammensetzung zur notfall-empfängnisverhütung |
US20040058975A1 (en) * | 2002-06-26 | 2004-03-25 | Schering Ag | Method for fertility control |
WO2006104406A1 (en) | 2005-03-31 | 2006-10-05 | Auckland Uniservices Limited | Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
WO2007045513A1 (de) | 2005-10-19 | 2007-04-26 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur präventiven bedarsweisen hormonalen kontrazeption |
WO2007091107A1 (en) | 2006-02-10 | 2007-08-16 | Summit Corporation Plc | Treatment of duchenne muscular dystrophy |
WO2008070599A1 (en) | 2006-12-05 | 2008-06-12 | Chung-Ming Sun | Indazole compounds |
WO2010119029A1 (en) | 2009-04-14 | 2010-10-21 | Laboratoire Hra-Pharma | Method for on-demand contraception |
WO2010119030A1 (en) | 2009-04-14 | 2010-10-21 | Ulmann Andre | Method for on-demand contraception using levonorgestrel or norgestrel |
WO2010124102A1 (en) | 2009-04-22 | 2010-10-28 | Janssen Pharmaceutica Nv | Azetidinyl diamides as monoacylglycerol lipase inhibitors |
WO2010149273A1 (de) | 2009-06-23 | 2010-12-29 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische zusammensetzung zur notfallempfängnisverhütung |
DE102009049662A1 (de) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten |
WO2011069871A1 (en) | 2009-12-09 | 2011-06-16 | Laboratoire Hra-Pharma | A method for providing emergency contraception using ulipristal acetate |
WO2011091892A1 (en) | 2010-02-01 | 2011-08-04 | Ulmann Andre | A method for late post coital contraception using ulipristal acetate |
WO2013079425A1 (en) * | 2011-11-28 | 2013-06-06 | Bayer Intellectual Property Gmbh | Novel 2h-indazoles as ep2 receptor antagonists |
Non-Patent Citations (23)
Title |
---|
AITKEN ET AL., CONTRACEPTION, vol. 78, 2008, pages S28 - S35 |
ALISON B. EDELMAN ET AL: "Impact of the prostaglandin synthase-2 inhibitor celecoxib on ovulation and luteal events in women", CONTRACEPTION, vol. 87, no. 3, 1 March 2013 (2013-03-01), pages 352 - 357, XP055122561, ISSN: 0010-7824, DOI: 10.1016/j.contraception.2012.07.004 * |
ATHANASIOUS ET AL., FERTIL STERIL., vol. 65, no. 3, 1996, pages 556 - 60 |
BATA ET AL., J CLIN PHARMACOL, vol. 46, 2006, pages 925 - 932 |
CANZLER ET AL., GYNÄKOL., vol. 106, 1984, pages 1182 - 1191 |
CASTELLSAGUE ET AL., DRUG SAF., vol. 35, no. 12, 2012, pages 1127 - 46 |
CHENG JG; STEWART CL., BIOL REPROD., vol. 68, no. 2, 2003, pages 401 - 4 |
CRISTIÁN JESAM ET AL: "Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception", HUMAN REPRODUCTION, OXFORD JOURNALS, GB, vol. 25, no. 2, 1 February 2010 (2010-02-01), pages 368 - 373, XP002670300, ISSN: 0268-1161, [retrieved on 20091119], DOI: 10.1093/HUMREP/DEP392 * |
EDELMANN ET AL., CONTRACEPTION, vol. 81, no. 6, 2010, pages 496 - 500 |
EDELMANN ET AL., CONTRACEPTION, vol. 87, no. 3, 2013, pages 352 - 357 |
HIZAKI ET AL., PROC NATL ACAD SEI U. S. A, vol. 96, no. 18, 1999, pages 10501 - 10506 |
HUNTJENS ET AL., RHEUMATOLOGY, vol. 44, 2005, pages 846 - 859 |
JESAM ET AL., HUM REPROD, vol. 25, no. 2, 2010, pages 368 - 73 |
KILLICK S; ELSTEIN M., FERTIL STERIL., vol. 47, no. 5, 1987, pages 773 - 7 |
LIM ET AL., CELL, vol. 91, no. 2, 1997, pages 197 - 208 |
MASSAI, HUMAN REPRODUCTION, vol. 22, no. 2, 2007, pages 434 - 439 |
MATSUMOTO ET AL., BIOLOGY OF REPRODUCTION, vol. 64, 2001, pages 1557 - 1565 |
OPARE-ADDO ET AL., AFR. J. REPROD. HEALTH., vol. 15, no. 1, 2011, pages 65 - 7 |
PALL ET AL., HUMAN REPRODUCTION, vol. 16, no. 7, 2001, pages 1323 - 1328 |
PELUFFO ET AL., ANNUAL MEETING OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE, 2012 |
RAYMOND ET AL., OBSTET GYNECOL., vol. 117, no. 3, 2011, pages 673 - 81 |
VANDERHYDEN ET AL., DEV BIOL., vol. 140, no. 2, 1990, pages 307 - 317 |
VARAS-LORENZO ET AL., PHARMACOEPIDEMIOL DRUG SAF., 2013 |
Also Published As
Publication number | Publication date |
---|---|
CL2015003434A1 (es) | 2016-07-22 |
TW201522325A (zh) | 2015-06-16 |
MX2015016121A (es) | 2016-03-31 |
AR096386A1 (es) | 2015-12-30 |
AU2014270596A1 (en) | 2015-12-03 |
TN2015000511A1 (en) | 2017-04-06 |
KR20160014598A (ko) | 2016-02-11 |
CA2913085A1 (en) | 2014-11-27 |
EP2999469A1 (de) | 2016-03-30 |
US20160089364A1 (en) | 2016-03-31 |
US9655887B2 (en) | 2017-05-23 |
UY35584A (es) | 2014-12-31 |
JP2016518456A (ja) | 2016-06-23 |
CN105451737B (zh) | 2018-04-10 |
EA201592207A1 (ru) | 2016-06-30 |
HK1217640A1 (zh) | 2017-01-20 |
PH12015502598A1 (en) | 2016-02-29 |
CN105451737A (zh) | 2016-03-30 |
BR112015029214A2 (pt) | 2017-07-25 |
JP6370887B2 (ja) | 2018-08-08 |
MA38606A1 (fr) | 2017-03-31 |
AP2015008855A0 (en) | 2015-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6647371B2 (ja) | 1,3−チアゾール−2−イル置換ベンズアミド | |
JP7033079B2 (ja) | 芳香族スルホンアミド誘導体 | |
EP2785707B1 (de) | Neue 2h-indazole als ep2-rezeptorantagonisten | |
EP0222191B1 (de) | 4-Benzyl-1-(2H)-phthalazinon-Derivate | |
EP3083603B1 (de) | Benzimidazolderivate als ep4-liganden | |
WO2007037534A1 (ja) | 2-へテロアリール置換インドール誘導体 | |
DE60020560T2 (de) | Substituierte pyrazol-derivate | |
CN112513020A (zh) | 用于治疗疾病的kdm1a抑制剂 | |
CN111527090B (zh) | 作为p2x3抑制剂的吡唑并-吡咯并-嘧啶-二酮衍生物 | |
JP2022538270A (ja) | 3-(5-メチル-1,3-チアゾール-2-イル)-n-{(1r)-1-[2-(トリフルオロメチル)ピリミジン-5-イル]エチル}ベンズアミドのアナログ | |
CN110325523B (zh) | 作为缓激肽b1受体拮抗剂的羧酸芳族酰胺 | |
DE602005005490T2 (de) | (1,10b-dihydro-2-(aminocarbonylphenyl)-5h-pyrazoloä1,5-cüä1,3übenzoxazin-5-yl)phenylmethanonderivate als inhibitoren der viralen hiv-replikation | |
WO2014187744A1 (de) | Pharmazeutische zusammensetzung und deren verwendung sowie anwendungsregime dieser pharmazeutischen zusammensetzung zur bedarfsweisen („on-demand") kontrazeption | |
DE69909592T4 (de) | Verwendung von thiadiazolo[4,3-a]pyridine derivaten | |
WO2014187793A1 (de) | Verwendung einer pharmazeutischen zusammensetzung zur notfallkontrazeption | |
TW201524967A (zh) | 緊急避孕醫藥組合物之用途 | |
Bräuer et al. | 2H-indazoles as EP 2 receptor antagonists | |
EP4089079A1 (de) | Ror-gamma-t-inhibitor, herstellungsverfahren dafür und verwendung davon | |
NZ624722B2 (en) | Novel 2h-indazoles as ep2 receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201480041669.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14724746 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 242581 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12015502598 Country of ref document: PH |
|
ENP | Entry into the national phase |
Ref document number: 20157032972 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2913085 Country of ref document: CA Ref document number: 2016514342 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 38606 Country of ref document: MA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: P1567/2015 Country of ref document: AE Ref document number: 14893508 Country of ref document: US Ref document number: MX/A/2015/016121 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2014724746 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2014270596 Country of ref document: AU Date of ref document: 20140516 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112015029214 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201592207 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: A201512521 Country of ref document: UA Ref document number: IDP00201508667 Country of ref document: ID |
|
ENP | Entry into the national phase |
Ref document number: 112015029214 Country of ref document: BR Kind code of ref document: A2 Effective date: 20151123 |